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Abstract
This thesis focuses on the treatment of micronutrient deficiency, specifically hypomagnesemia,
through the synthesis and solution- and solid-state characterization of “pharma grade”, biorelevant
magnesium complexes (nutraceuticals) utilizing short-chain peptides (di- and tri-), pyrones, and
amino acids. There is further emphasis placed on determining the in vitro uptake of all produced
complexes. This work aims to mitigate the shortcomings of current magnesium supplements and
better illustrate an understanding of the factors impacting magnesium uptake.
Specifically, 1) There is a paucity of information regarding the coordination of biorelevant
ligands to magnesium, most of which was investigated between the 1950s and 1980s, and that
provided inconclusive structural determination of the resultant complexes and their impurities.
2) Current magnesium supplements suffer from a lack of proper characterization given an
absence of strict regulations as are present in pharmaceuticals
3) The most ubiquitously used magnesium supplements often place emphasis on a high
percentage magnesium composition, but exhibit poor water solubility and subsequently poor
bioavailability thus resulting in less substantial magnesium uptake
Q1. (Chapter 2) What is the expected ligand coordination of magnesium complexes and how does
Mg2+ coordination manifest when probed utilizing 1D and 2D 1H/13C NMR?
Goals: Synthesize and characterize a series of Mg2+ complexes utilizing pyrones and amino
acids and employ 1D and 2D 1H/13C NMR to determine the mode of coordination assumed by the
Mg2+ coordinate ligands. Furthermore, better outline how Mg2+ coordination is observed and
manifested on NMR spectra (e.g., signal intensity reduction, resolution changes, shifting, etc.)

Q2. (Chapter 3) Given the affinity for water of Mg2+, can solid-state methods be employed to
determine the degree of complex hydration and elucidate the general composition of the Mg2+complex core composition and provide additional insight as to the coordination mode of Mg2+
coordinate ligands?
Goals: To utilize thermal analyses (TGA/DSC) and elemental analysis to determine the
degree of hydration exhibited by the synthesized Mg2+ complexes and to determine the core
structure of said synthesized complexes.
Q3. (Chapter 4) How does Mg2+ complex solubility impact the overall cellular uptake of Mg2+
from synthesized complexes?
Goals: To determine the solubility of synthesized Mg2+ complexes and determine if there
is a relationship between the solubility of the complexes and the observed in vitro uptake of Mg2+
from the respective complexes.
Q4. (Chapter 6) Can other complexes using similar biorelevant metals (e.g., Zn2+) be characterized
in a similar way and does ligand coordination differ from that observed for Mg2+?
Goals: To determine if analogous complexes utilizing different biorelevant divalent cations
(e.g., Zn2+) can be synthesized and characterized in a similar fashion. Additionally, to determine
if different metals exhibit different observables when characterized utilizing NMR, given
difference in electron configuration, electropositivity/electronegativity.
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Chapter 1. Introduction
1.1 Introduction to Magnesium (Mg2+)
Magnesium (Mg2+) is a grayish metal,1 First recognized as an element as early as 1755,
and isolated in 1808 by Sir Humphry Davy.2,3 Mg2+ has atomic number 12 and an atomic weight
of 24.3 g/mol.1 Other physical and chemical properties include a melting point of 649°C, a density
of 1.738 g/cm3, and an electronegativity of 1.56.1 Mg2+ is found predominantly in the earth’s crust
as complex minerals, with the most biologically available source located in the hydrosphere.4,5
Mg2+ exhibits an extensive hydration sphere, with the hydrated radius being approximately 400
times larger than the dehydrated radius.4 When complexed and in solution, Mg2+ acts as an
electropositive di-cation (Mg2+), making it ideal for the coordination of Lewis bases.6

1.2 Biological Significance of Magnesium
Evidence supporting the biorelevance of Mg2+ is abundant and clear4,7,8 Mg2+ is the fourth
most common element in the human body and the second most common intracellular cation, after
potassium.4,8 Mg2+ is implicated for some 80% of metabolic function and acts as a cofactor for
more than 300 enzymes and 800 proteins.4,8,9 Most notably, Mg2+ is required for oxidative
phosphorylation, glycolysis, and energy production, where it acts as a cofactor for the production
of adenosine triphosphate (ATP) – Figure 1.4,8,10

1

Figure 1. Structural depiction of the extracellular magnesium-ATP complex found in
blood.4

Mg2+ is also required for the synthesis of deoxyribonucleic acid (DNA),11,12 ribonucleic
acid (RNA),13,14 and the antioxidant glutathione (GSH).15 Mg2+ also facilitates the active transport
of calcium (Ca2+) and potassium (K+) ions across cell membranes, demonstrating its importance
in functions such as muscle contraction and nerve impulse conduction.16–18 Given the impact that
Mg2+ has on calcium transport, it is not surprising that it is also required to maintain calcium
homeostasis between bone and blood.19

1.2.1 Distribution of Mg2+ in the Body
The average adult body contains ~25 g (1000 mmol) of Mg2+.20,21 However, the distribution
of Mg2+ in the human body is vastly disproportionate, with approximately 99% of Mg2+ existing
intracellularly (90% stored in bone and muscle tissue and < 1% distributed in blood).22–24 Of all
intracellular magnesium, only 2 – 3% is considered free and the concentration of this magnesium
is 0.5 – 0.6 mmol/L.21 Approximately 50 – 60% of all intracellular Mg2+ is stored exclusively in
bone,4 with Mg2+ concentrations in muscle and soft tissues accounting for 27% and 19%,
respectively.22 Given high concentrations of Mg2+ in bone, there is a delicate homeostasis
maintained between serum Mg2+ and available Mg2+ residing in outer layers of bone.25
2

Serum
Serum

19%
27%

50 – 60%

Figure 2. Distribution of Mg2+ in the human body (left) and distribution of serum Mg2+
(right).

Only ~1% of total body Mg2+ is found in serum, at concentrations of 0.7 – 1.1 mmol/L
(Figure 2).4,21 Of the Mg2+ in serum, approximately 55% exists in the free or ionized state and
accounts for the greatest level of biological activity,21 most notably for Ca2+ transport, and as a
Ca2+ antagonist (e.g. decreased free serum [Mg2+] causes increased [Ca2+], which results in
increased contractility of smooth muscles (i.e. cardiac)).21,26 Approximately 30% of serum
magnesium is found bound to proteins, with albumin representing the majority.27,28 The remaining
15% of serum magnesium is found complexed to biological anions such as ATP (i.e. phosphate
(PO43-); see Figure 1), carbonate (CO32-), or citrate (C6H5O73-) (Figure 3).

3

Magnesium Carbonate

Magnesium Citrate

Magnesium Phosphate

Figure 3. Structures of magnesium carbonate, magnesium citrate, and magnesium citrate formed
by serum Mg2+. “X” indicates the ability to form complexes of variable stoichiometric ratio.

1.2.2 Absorption of Mg2+ in the Gastrointestinal (GI) Tract
There is a delicate maintenance of Mg2+ homeostasis, with contributions from bone (e.g.
exchange of bone and serum Mg2+),4 the kidneys (e.g. renal excretion),29,30 and the intestines (e.g.
absorption).4 Mg2+ uptake in the body occurs in the lower GI, with independent sections (e.g.
duodenum, jejunum, ileum, etc.) exhibiting unequal levels of absorption,4,31–39 with the majority
of uptake occurring in the ileum (~56%).

4

GI Tract Segment

pH

Contribution of Magnesium Uptake (%)

Reference

Duodenum

5.9–6.8

11

4, 31 - 39

Colon

5.7–7.2

11

4, 31 - 39

Jejunum

5.9–6.8

22

4, 31 - 39

Ileum

7.3–7.6

56

4, 31 - 39

Table 1. Mg2+ uptake from sections of the GI.

The pH of the GI varies per section with an overall range of 5.7 – 7.6 (ΔpH = 1.9).32
Absorption of Mg2+ in the GI has subsequently been correlated to pH, as has been illustrated by
the work of Thongon et al.31,40 The increased uptake of Mg2+ in the ileum is largely attributed to a
more acidic luminal pH.33

1.2.3 Introduction to the Mg2+ Uptake Pathways
There are two pathways that contribute to the uptake of Mg2+ once absorbed in the lower
GI.: the saturable, active Transcellular Pathway (TP) and the non-saturable Passive Paracellular
Pathway (PPP).4,7,8 The TP is responsible for the uptake of small magnesium loads (~125 – 250
mg) while the PPP is responsible for the uptake of larger magnesium loads (≥ ~250 mg).4

5

1.2.3.1 Mechanism of the PPP
The PPP is responsible for the uptake of 80 – 90% of total Mg2+ in the body (accounting
for Mg2+ loads of ≥ ~250mgs),24,41 although the exact mechanism is still unknown.7 Absorption
via the PPP is gradient driven electrochemically and also by solvent drag of Mg2+ between
intestinal enterocytes.4 This effect is a result of high luminal concentrations of Mg2+ (1 – 5
mmol/L) and the lumen-positive transepithelial voltage (~ 5 mV).7,42 The PPP depends upon the
passage of ions such as Mg2+ through tight junctions (TJ),4 which is complicated by the extensive
hydration sphere exhibited by Mg2+.4,8 For passage through TJ, a series of proteins called claudins
are employed by the PPP (Figure 4).4,8,43

Figure 4. Passage of Mg2+ through TJ facilitated by claudins utilizing the PPP. Created with
BioRender.
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In general, claudins are responsible for stripping Mg2+ of its extensive hydration sphere to
allow for passage through TJ. Currently, there are 26 identifiable claudins and subsets of these
claudins serve differing barrier functions.43,44 Claudins -1, -3, -4, -5, -8, -11, -14, and -19 have
been identified in an extensive review by Amasheh et al. as barrier builders, claudins -2 and -10
as permeability mediators, and claudins -7, -12, and -15 as ambiguous.43 An extensive review by
de Baaij et al.8 further highlights claudin function, indicating that claudins -16 and -19 are most
responsible for Mg2+ uptake, as was further illustrated by Konrad et al.45 upon Claudin -16 and 19 mutation resulting in renal wasting of Mg2+ as well as renal failure.45 The true function of
claudin-16 is currently debated, but it is believed that it acts to mediate the epithelial voltage
gradient by controlling the Na+ back-leak.8,46–48 While less extensively explored, claudin-19 has
been further implicated in Mg2+ uptake.49

1.2.3.2 Mechanism of the TP
The TP is responsible for smaller Mg2+ loads (~125 – 250 mg).4 Uptake in the TP is
controlled by the presence of transient receptor potential channel melastatins – predominantly
members 6 (TRPM6) and 7 (TRPM7) (Figure 5).8 TRPM7 is ubiquitously expressed, however,
TRPM6 has been shown to be expressed predominantly in the lower intestine of murine tissue,
although not confirmed in humans.8,50 Expression of TRPM6 and TRPM7 is limited to enterocytes
– namely within the luminal membrane.8 The exact mechanism of transport has yet to be
elucidated, but could be gradient based as is the case with the PPP.8
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Transcellular Pathway
Lumen

Figure 5. Uptake of Mg2+ via the TP as facilitated by TRPM6 and TRPM7.
Created with BioRender.

1.2.4 Renal Filtering of Mg2+
As part of homeostatic maintenance, excess Mg2+ must be excreted renally.4,7,8 The
glomeruli is responsible for the filtering of approximately 2400 mg/day of Mg2+. Of the 2400mg
of Mg2+ filtered, only about 100 mg/day are excreted in urine – the other 90 – 95% of Mg2+ is
reabsorbed along the nephron.7 As is the case with Mg2+ uptake along the GI, Mg2+ reabsorption
is also unequal along the nephron. The nephron can be broken into three main sections: the
proximal tubule (PT), the thick ascending limb (TAL), and the distal convoluted tubule (DCT).
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Reabsorption of Mg2+ in the Nephron

Figure 6. Reabsorption of Mg2+ in different parts of the nephron before renal
passing (made in BioRender).

As shown (Figure 6), Henle’s Loop is responsible for the majority of Mg2+ reabsorption
accounting for up to 70% - with predominant focus on the TAL.7 The TAL consists of a cortical
segment, where magnesium uptake occurs, and a medullary segment, which is not responsible for
any magnesium reabsorption.51,52 Uptake in the TAL is predominantly paracellular.51
In newborns, the PT constitutes ~70% of overall magnesium reabsorption.51,53 In adults,
the PT accounts for the second highest level of magnesium reabsorption – constituting
approximately 10 – 25% of the overall total.7,51,54 Absorption in the PT is gradient based and
paracellular in nature at high Mg2+ concentrations.7
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The DCT accounts for the smallest amount of Mg2+ reabsorption at only ~ 10% of Mg2+.7,51
Unlike the PT and the TAL, Mg2+ reabsorption in the DCT is predominantly transcellular and
requires the presence of the TRPM6 pathway for Mg2+ to enter the cell.7
Considering the DCT to be the end of the Mg2+ reabsorption pathway, the kidney is then
responsible for excreting Mg2+.7 Renal excretion of magnesium varies in cases of increased Mg2+
intake or in renal failure when the kidney will excrete Mg2+ fractionally to maintain homeostasis
as required until onset hypomagnesaemia.7

1.3 Determining Mg2+ Status in Humans
It is estimated that some 50 – 60% of the U.S. population is afflicted by chronically low
Mg2+ levels (hypomagnesaemia), however, these estimates may be even lower than the real number
of individuals impacted.8 Determining Mg2+ status in humans is complicated by the previously
mentioned unequal distribution of Mg2+ in the body.4,55 Analyzing serum Mg2+ remains the most
used method for determining overall Mg2+ status.56 However, given the disparity in Mg2+
distribution, serum analysis is not sufficient to determine true body Mg2+ values.4 There are other
methods of body Mg2+ determination including isotopic analysis as well urine analysis and
retention testing, but these, too, are not without shortcomings.4
1.3.1. Urinary Analysis and “Loading Test” to Evaluate Mg2+ Status
Urinary analysis provides information mostly beneficial in determining the degree of renal
wasting of Mg2+ or inadequate Mg2+, but does not indicate actual Mg2+ quantity.4,22 Mg2+ loading,
or an Mg2+ retention test, provides a means of determining whether or not an individual is in a
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hypomagnaesemic state by evaluating serum Mg2+ after an oral administration of Mg2+, but may
also be evaluated by examining bone Mg2+ content.4 Increases in serum Mg2+ after acute oral
dosing are attributed to adequate absorption of Mg2+ by the GI.4,22,57 Furthermore, evaluation of
Mg2+ status is correlated to bone levels of Mg2+, and can quantify Mg2+.4,57 As pointed out by
Fawcett et al., however, this method of analysis is not fully standardized.27
1.3.2. Evaluating Mg2+ Status Isotopically
Mg2+ status may be evaluated isotopically.4 There are three non-radioactive Mg2+ isotopes
(24Mg,

25

Mg, and

26

Mg) which occur in relative abundance of 78.7%, 10.1%, and 11.2%,

respectively.58 Although isotopic Mg2+ allows for a direct quantification method of Mg2+, analysis
is complicated by short half-life times of the respective isotopes.4,22 The fourth Mg2+ isotope, 28Mg,
is radioactive and decays by emission of high-energy beta or gamma particles.4 Given the
shortcomings of Mg2+ isotopes, they are typically restricted to research use only and not clinical.4
1.4. Hypomagnesaemia
Mg2+ deficiency, or hypomagnesaemia (defined as < 0.75 mmol/L in serum),55 is not a
novel concept. In fact, hypomagnesaemia has been documented as far back as the early 20th
century.59–62 Hypomagnesaemia is a micronutrient deficiency that drastically impacts the
developed world. In fact, it is estimated to impact some 50 – 60% of the American population
alone,63–65 but as outlined in section 1.3, given complications in evaluating Mg2+ status, this
number is probably substantially higher. There are many factors that contribute to
hypomagnesaemia, such as increased renal wasting due to disease states (e.g. alcoholism, Type 2
Diabetes Mellitus (T2DM), etc.) or poor absorption in the GI.23 However, the prevalence of
hypomagnesaemia in developed countries is attributed predominantly to poor diet.23 Inadequate
11

intake is further attributed to changes in diet that favor fast foods and processed foods as opposed
to more organic, micro-nutrient rich foods.22,66,67 While rather widespread, hypomagnesaemia
often goes undiagnosed,68,69 with chronic latent hypomagnesaemia further correlated to other
chronic disease states.
1.4.1 Hypomagnesaemia in Chronic Disease
Hypomagnesaemia has been identified as an impacting factor in several chronic disease
states. Specifically, hypomagnesaemia has been implicated in cardiac disorders (e.g. arrythmia),70
bone disorders (e.g. osteoporosis),19,59,71 hypertension,70 headaches/seizures,9,72 and T2DM.73–76
1.4.1.1 Mg2+ in Heart Health
Given the impact that Mg2+ has on nerve impulse conduction,16–18 it is no surprise that
presence of the cation definitively impacts heart health. It has been shown that a deficiency of
Mg2+ increases the presence of sodium and calcium in the heart; increased concentrations of these
ions contribute to vasoconstriction, arterial spasm, and subsequently may cause cardiac arrest.
Furthermore, Mg2+ supplementation has been shown to decrease blood pressure77 and may be used
intravenously to reduce the number of experienced arrythmias.78
1.4.1.2. Mg2+ in Osteoporosis
Mg2+ has been shown to impact osteoporosis as discussed briefly in an extensive review on
the clinical impact of hypomagnesaemia by de Baaij et al.8 In general, studies indicate that
osteoporosis may be attributed to hypomagnesaemia, as it may be treated via oral Mg2+
supplementation and bone loss may be observed upon Mg2+ reduction.59,79 Most studies are
conducted on postmenopausal women,8,80 but others have been conducted on the elderly and have
12

indicated, that although marginally, Mg2+ supplementation increases Mg2+ loading, thus indicating
substantial Mg2+ uptake.81
1.4.1.3. Mg2+ in T2DM
In a study conducted by Rodriguez-Moran et al., Mg2+ supplementation was shown to
positively impact patients with T2DM.82 As reported, when treated with Mg2+ in the form of
MgCl2, treated subjects exhibited a decrease in overall fasting glucose as well as Hemoglobin A1c
(HbA1c) and other diabetic metrics.82 Thus indicating that Mg2+ supplementation has a positive
impact on T2DM.
1.5. Mg2+ Supplementation to Treat Hypomagnesaemia
1.5.1. Introduction to Mg2+ Supplements and Understanding Oxides and Salts
Provided the biological impact of Mg2+ on general health, methods of palliating
hypomagnesaemia have been utilized, with both acute and chronic Mg2+ supplementation at the
fore.4,82–84 Mg2+ supplementation has been studied in pregnant women,85 athletes,86 and patients
with osteoporosis (given the delicate homeostasis maintained between Mg2+ and Ca2+).59,80,87 To
date, the most commonly used Mg2+ supplements are the oxides/hydroxides of magnesium
(MgO/MgOH) and magnesium salts (e.g. magnesium chloride (MgCl2 • xH2O) and magnesium
citrate). However, several other supplements are utilized (Table 2).
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Form
(Oxide/Salt/Chelate)

Acid/Base Chemistry

Solubility
(g/100 mL H2O)

MW g/mol (%Mg)

Reference

Magnesium Oxide

Alkaline

0.010

40.30 (60.3)

88

Magnesium Citrate

Acidic (pKa1 = 3.13)

20

214.41 (11.3)

1

Magnesium Chloride

Neutral

54.0

95.21 (25.5)

89

Magnesium Sulfate

Acidic (pKa1 = 3.0; pKa2 = 1.99)

35.7

120.37 (20.1)

88

Magnesium Orotate

Acidic (pKa1 = 2.83)

Slightly Soluble

334.48 (7.2)

90

Magnesium Taurate

Acidic (pKa = 1.50)

Slightly Soluble

272.57 (8.9)

91

4.0

288.49 (8.5)

92

Soluble

294.50 (8.3)

93

Slightly Soluble

156.37 (15.5)

94,95

Acidic (pKa1 = 1.88; pKa3 =
Magnesium Aspartate
3.65)
Magnesium Threonate

Acidic (pKa1 = 3.4)
Acidic (pKa1 = 3.46; pKa2 =

Magnesium Malate
5.10)
Magnesium Hydroxide

Alkaline

0.00069

58.32 (41.7)

88

Magnesium Carbonate

Weakly Alkaline

0.18

84.31 (28.8)

1

Table 2. Commonly used Mg2+ supplements and form, acid/base chemistry, solubility, and %Mg
composition.

MgO is most frequently used given its high %Mg composition, whereas MgCl2 and
magnesium citrate are utilized given biocompatibility and substantial aqueous solubility. There
are, however, shortcomings to the oxide and salt forms of Mg2+ supplements: MgO exhibits low
aqueous solubility relative to other Mg2+ supplements at only 0.010 g/100 mL,88 and the laxative
effects of Mg2+ salts are well defined.4 Other Mg2+ supplements, such as magnesium malate95 and
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magnesium threonate93 represent a third supplemental form: Mg2+-chelates, which provide a
means of successfully navigating the shortcomings of current oxide and salt Mg2+ supplements.
1.5.2. Introduction to Mg2+-Chelates
Mg2+-chelates are typically synthesized utilizing biorelevant chelate ligands such as
ligands implicated in biological processes (formic acid/formate)96 or amino acids,97 to aid in
overall complex aqueous solubility as well as stability given coordination of a higher degree
(mono, bi, tridentate, etc.). Increased solubility is desirable given a correlation between complex
solubility and bioavailability.98–100 While promising, Mg2+-chelates are often poorly characterized
which impacts metrics of supplemental use such as appropriate dosing and modes of action. In
fact, very few Mg2+-chelates are fully characterized.
1.5.2.1. A Brief Discussion of Characterized Biorelevant Mg2+ Complexes
Few Mg2+-chelate complexes have been fully characterized, outside of select few outlined
in the works of Schmidbauer et al.97,101–105, and others outlined in an extensive review by Case et
al. (Table 3).106 Early studies of Mg2+-chelate complexes, such as those conducted by Martell et
al. on short-chain glycine peptides, were limited to titrimetric analysis, which was used to
determine complex speciation,107–109 but provided tentative assignments and could not confirm the
assumed coordination mode of ligand. While crystallization would provide definitive information
as to complex composition and assumed coordination mode, crystallization of Mg2+-chelates is
often complicated by the extensive hydration sphere observed for Mg2+,4 and the inherent disorder
imparted by such waters. While Mg2+-chelates are a promising means of Mg2+ supplementation,
other means of characterization must be employed to definitively confirm species coordination
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mode and composition, as to generate fully-characterized, pharmaceutical-grade Mg2+
supplements – or nutraceuticals.

Ligand

pKa1

pKa2

pKa3

Lewis Bases

2.83

---

---

1

3.41

---

---

2

2.14

4.85

---

2

3.75

---

---

1

2.34

9.60

---

2

3.40

5.11*

---

3

1.83

---

---

2

1.88

9.60

---

3

2.19

9.67

---

3

Orotic Acid

Mandelic Acid

Anthranilic Acid

Formic Acid

Glycine

Malic Acid

Maleic Acid

Aspartic Acid

Glutamic Acid

16

Citric Acid

3.13

4.76 *

6.40

4

Table 3. Characterized and reported Mg2+ supplements outlined in the review by Case et. al.106

1.5.3. Nutraceuticals
The term nutraceutical was first coined by Dr. Stephen DeFelice in 1989 as a portmanteau
of the words “nutrition” and “pharmaceutical”.110 For a time, there was no regulatory operative
definition of a nutraceutical,110 and thus there was a discrepancy between what constituted a
nutraceutical or a functional food. As of 2003, Dr. Ekta K. Kalra, proposed a means of redefining
nutraceuticals as based upon the Dietary Supplement and Health Education Act (DSHEA) of 1994,
which outlined criteria to constitute a dietary supplement. As such, Dr. Kalra proposed the
operative definition of a nutraceutical such that it must not only supplement diet, but aid in the
treatment of disease.110 Facing scrutiny from the FDA as to what constitutes justifiable claims and
safety of nutraceuticals,111 further adaptation of the operative definition of nutraceutical is
required, and as such the term should be amended to include full complex characterization.

1.6. Summary
The aim of this research was to synthesize Mg2+ complexes utilizing biorelevant ligands,
with the intent of outlining methods that may be used to confirm ligand coordination to Mg2+ and
hydrated state, thus allowing for full characterization in both the solution- and solid-state, as to
17

generate novel nutraceuticals for the treatment of hypomagnesaemia. Utilizing the biorelevant
ligands maltol, ethylmaltol, glycylglycine (HG2) and glycylglycylglycine (HG3) shown in Figure
7.

Figure 7. Proposed ligands utilized to generate Mg2+-chelate nutraceuticals.

Maltol

(IUPAC:

3-hydroxy-2-methyl-4H-pyran-4-one),

HG2

(IUPAC

–

(2-

Aminoacetamido)acetic acid), and HG3 (2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetic acid)
were selected given their natural occurrence and isolation,112,113 and ethylmaltol (IUPAC: 2-ethyl3-hydroxy-4H-pyran-4-one) was selected given its generally regarded as safe (GRAS) status.114
All ligands were further promising given access to multidentate coordination (bi, tri, and
tetradentate) coordination modes. Additionally, all three ligands exhibit substantial aqueous
solubility.115–117
Chapter 2 focuses predominantly on the characterization of complexes 1 – 4 in the solution
state via 1D and 2D 1H/13C NMR and how Mg2+ coordination manifests as an observable. Chapter
18

3 focuses on determining the hydrated state of complexes 1 – 4 and determining overall complex
composition. Chapter 4 evaluates the solubility of 1 – 4 and the resulting observed cellular uptake
as it relates to %Mg2+ composition. Given the positive results exhibited by 1 – 4, Chapter 6 focuses
on the application of determined synthetic methods and utilized ligands to other biorelevant metals
such as zinc (Zn2+).
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Chapter 2. The Effect of Magnesium Coordination on the 1H/13C Nuclear Magnetic
Resonance of Magnesium-Coordinate Ligands
All work in this chapter was completed by the author. Work in this chapter was published in:
•
•
•

Case, D. R.; Zubieta, J.; Gonzalez, R.; Doyle, R. P. Synthesis and Chemical and
Biological Evaluation of a Glycine Tripeptide Chelate of Magnesium. Molecules
2021, 26 (9), 2419.
Case, D. R.; Gonzalez, R.; Zubieta, J.; Doyle, R. P. Synthesis, Characterization,
and Cellular Uptake of a Glycylglycine Chelate of Magnesium. ACS Omega.
Published ahead of print online 11/30/2021 DOI: 10.1021/acsomega.1c04146.
Case, D. R.; Gonzalez, R.; Zubieta, J.; Doyle, R. P. Synthesis, Characterization,
and Cellular Uptake of Magnesium Maltol and Ethylmaltol Complexes. ACS
Omega 2021, 6 (44), 29713-29723.

2.1. Introduction
As more fully described in chapter 1, Mg2+ readily coordinates with hard Lewis bases as
exemplified by the monodentate magnesium chelates of formic acid,1 orotic acid,2 maleic acid,3
the bidentate magnesium chelates of mandelic acid4 and malic acid,5 and the tridentate magnesium
chelate of citric acid.6,7 It is generally accepted that ligand chelation to the divalent Mg2+ cation is
often characterized by an observable upfield shift in the 1H nuclear magnetic resonance (NMR)
spectrum, or a change in signal resolution, of the proton signals adjacent to the Lewis bases of the
ligand, due to the electropositive character of the metal.
Additionally, Mg2+ coordination is manifested in 13C NMR either by shifting, most often
downfield, or via a change in carbon signal intensity/resolution.8,9 These shift/intensity changes
are exhibited by the carbons adjacent to the coordinate ligands, moieties that are implicated in
Mg2+ coordination. Occurrences of this type are notably exemplified by magnesium complexes of
ofloxacin and levofloxacin.8
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Figure 1. Structures of the magnesium coordinate ligands maltol, ethylmaltol, glycylglycine
(HG2) and glycylglycylglycine (HG3), including IUPAC naming conventions, used in this study.

While 1-Dimensional 1H/13C NMR is satisfactory to determine Mg2+-complex formation,
it is not enough to fully assign all proton and carbon identities, and as such is inconclusive in fully
confirming the ligand coordination mode. Therefore, 2-Dimensional 1H/13C NMR in the form of
heteronuclear single quantum coherence (HSQC) and heteronuclear multiple bond correlation
(HMBC) were employed herein to investigate coordination modes. To this end, a combination of
both 2D NMR techniques confirmed the identities of all proton and carbon signals thus
ascertaining the ligand coordination mode. Given the impact that concentration may have on the
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shifting of proton and carbon signals, it is important to note here that all samples were compared
and analysed at equimolar concentration.
Coordination of maltol (Figure 1a) and ethylmaltol (Figure 1b) to Mg2+ is predicted to
occur in a bidentate fashion utilizing the ketone moiety and the deprotonated terminal alcohol,
whereas the coordination of HG2 (Figure 1c) and HG3 (Figure 1d) is expected to be tridentate and
tetradentate, respectively. Thus, we set out to assay chelate ligands across a spectrum of possible
coordinative modes with Magnesium, with each ligand (a)-(d) discussed below.
2.2. NMR Characterization of Maltol and 1
2.2.1. 1H NMR Characterization of Maltol and 1

Figure 2. The full 1H NMR of maltol with insets indicating the enhanced aromatic
region (left) and the enhanced aliphatic region (right) to display shifting and integration.
NMR was conducted in D2O.
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The 1H NMR of uncoordinated commercial maltol exhibits (Figure 2) three proton signals: two
aromatic signals exhibiting doublet splitting at 8.00/7.99 ppm and 6.51/6.50ppm, and one aliphatic
singlet at 2.38 ppm, attributed to H2, H1, and H3, respectively (Figure 2). The observed integration
for these signals was 1:1:3, as predicted.
Upon coordination of maltol to Mg2+, three proton signals attributed to the maltol ligand
were observed with the same splitting pattern: two aromatic doublets at 7.97/7.96 ppm and
6.50/6.49 ppm, and an aliphatic singlet at 2.35 ppm (Figure 3). A small but observable upfield
shift of all proton signals was observed however for 1. Upfield shifting was 0.03ppm for H2, 0.010.02ppm for H1, and 0.03ppm for H3, respectively (Figure 4). Additionally, the integration of
maltol and 1 is conserved. Upfield shifting of the observed proton signals is consistent with the
formation of 1 and the conservation of the integration is consistent with no change in the maltol
ligand – suggesting no other reactions independent of the formation of 1.

Sol

Figure 3. 1H NMR of 1. NMR was conducted in D2O.
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NMR analysis of 1 also exhibited a quartet with peaks between 2.51 – 2.72 ppm which is
attributed to magnesium citrate. Presence of magnesium citrate was confirmed via 1H NMR and is
a result of utilizing citric acid to solubilize the magnesium oxide starting material. The integration
of the peaks attributed to magnesium citrate indicate a percent composition of 7.2% magnesium
citrate (Figure 3 and Figure 4).

Figure 4. 1H NMR overlay of maltol (top) and 1 (bottom) at equimolar
concentration indicating the observed proton upfield signal shifting. NMR was
conducted in in D2O.

2.2.2. Confirmation of 1 Proton and Carbon Signal Determination Utilizing
Heteronuclear Single Quantum Coherence (HSQC) and Heteronuclear Multiple
Bond Correlation (HMBC)
Both 2D 1H/13C HSQC and HMBC NMR were utilized to confirm the proton and carbon
assignments for maltol and 2. As shown in Figure 5, the HSQC of maltol exhibited only one
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coherence point between the only saturated carbon and its only aliphatic proton. This is consistent
with the predicted 1H/13C spectrum of maltol.

Figure 5. Full 1H/13C HSQC NMR of maltol showing a zoomed (inset middle)
image of only one observed coherence point. NMR was conducted in D2O.

Along with the denoted integration of three observed for this proton on the 1H NMR
spectrum of maltol, this confirms the signal at 2.39 ppm as the H3 proton and confirms the identity
as the terminal methyl group of maltol. The carbon assignment at 13.95 ppm is also confirmed as
C6 given that this is the only carbon within a single bond length of this proton signal.
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The HMBC of maltol, as shown in Figure 6, was more elaborate, indicating the presence
of seven distinct signals – the number of observed signals was consistent with the predicted number
of observed signals and allowed for the complete assignment of all carbon signals.

Figure 6. Full 1H/13C HMBC NMR of maltol with the aromatic (inset bottom) and the
aliphatic (inset top) regions highlighted. NMR was conducted in D2O.

As illustrated, the H2 proton exhibits three correlative points: 113.40 ppm, 154.50 ppm,
and 175.20 ppm. The signal at 113.40 ppm is assigned to the C2 carbon signal given that this is the
only carbon that H2 would interact with across multiple bonds and there is no interaction of this
33

carbon with the H1 proton, which is the result of this carbon being only one bond length away from
the H1 proton. The signal at 154.50 ppm is attributed to the C4 carbon assignment given the distance
of this interaction is three bonds. While C3 and C4 are not substantially different, there is no
correlation between the H2 proton and C3 for the same reason that there is no interaction between
H1 and the assigned C2. Lastly, the signal at 175.20 ppm is attributed to the C1 assignment. This
assignment is not only consistent with the generally predicted region for ketone carbons but is also
supported by the secondary observed interaction of the C1 carbon with the H1 proton assignment,
which is only two bonds away. The interaction of both the H1 and H2 protons with this carbon
confirms the C1 assignment.
The H3 proton signal exhibited correlation to two carbon signals: 154.50 ppm and 142.00
ppm. Analysis of these points confirms the previously established C4 assignment at 154.50 ppm
and supports the assignment of C5 at 142.00 ppm. These assignments arise from differences in
signal intensity – given that signal at 142.00 ppm has a weaker signal intensity, it is predicted to
be farther way from the H3 proton, and thus is assigned as C5. Process of elimination subsequently
confirms the signal at 156.00 ppm is attributed to the C3 carbon assignment.
There were observed changes to the respective HSQC (Figure 7) and HMBC (Figure 8)
spectra of maltol upon coordination to Mg2+. Most notably, both spectra exhibited the presence of
peaks attributed to magnesium citrate, which is the result of citric acid utilization during complex
synthesis. Furthermore, while the HSQC observed signal remained the same with only one
observed signal, attributed to the interaction between the H3 proton and the C6 carbon, the ratio of
observed interactions on the HMBC spectra was substantially different. The ratio of observed
signals for the H1, H2, and H3 protons (previously observed as 3:3:2) had changed to an observed
2:3:1 ratio. With the proton assignments remaining the same, this change in the observed ratio of
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interaction points was attributed to changes in correlative carbon environments and was
subsequently probed utilizing 13C NMR.

Figure 7. Full 1H/13C HSQC NMR of 1 with observed signals zoomed (inset
bottom left). NMR was conducted in D2O.
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Figure 8. Full 1H/13C HMBC NMR spectra of 1 with both the aromatic (inset bottom
right) and aliphatic (inset top right) regions zoomed for clarity. NMR was conducted
in D2O.

2.2.3. Characterization of 1 Via 13C NMR
Missing proton/carbon interactions as observed on the HMBC spectrum of 1 prompted 13C
NMR analysis of 1 relative to maltol. Upon comparison, the respective spectra were noticeably
different.
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Figure 9. Full 13C NMR spectrum of maltol. NMR was conducted in D2O.
The 13C NMR spectrum of maltol (Figure 9) exhibited six carbon signals with only one
signal in the region attributed to saturated carbons (-CH3) and the other five signals within the
region attributed to C=C carbons and C=O carbons. These observations are consistent with the
predicted 13C NMR spectrum of maltol as based upon the structure. The carbon assignments for
these signals were made based upon the 1H/13C HSQC and HMBC analyses of maltol as previously
mentioned (see section 4.2.4.1).
As predicted, the

13

C NMR spectrum of 1 was substantially different comparatively. As

was the case with the 1H NMR of 1, so too did the
magnesium citrate (see Figure 10).
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C NMR exhibit signals attributed to

Figure 10. 13C NMR overlay of maltol and 1. * Indicates peaks attributed to magnesium
citrate. NMR was conducted in D2O.

Most striking, however, is the reduction in signal intensity of carbons C1 and C2, as well as
the complete disappearance of the C5 carbon – the ketone carbon, the carbon nearest the ketone,
and the carbon attributed to the terminal alcohol. These observations are consistent with the maltol
ligand coordinating to Mg2+ about the ketone and the deprotonated terminal alcohol. The decrease
in signal intensity of these carbons may be easily explained by the deprotonation of the terminal
alcohol and the coordination of the substantially electropositive Mg2+ causing a change in the
dipole moment of these moieties.
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Figure 11. Predicted resonance of maltol upon coordination to Mg2+.

Additionally, resonance is expected upon Mg2+ coordination (Figure 11) – subsequently,
a change in the D1 scan time to a wider window allowing for a longer analysis of relaxation might
give rise to the presence of these peaks. These observations support the coordination of maltol to
Mg2+ to be bidentate in nature about the ketone and the terminal alcohol.

2.3. NMR Characterization of Ethylmaltol and 2
2.3.1. 1H NMR Characterization of Ethylmaltol and 2
As predicted, the 1H NMR of ethylmaltol (Figure 12) exhibited four proton signals with
splitting like that of maltol, which is expected given only the addition of a -CH2 moiety to the
terminal methyl (-CH3) group. Signals are as follows: two aromatic doublets at 8.02/8.01 ppm and
6.50/6.49 ppm, an aliphatic quartet with signals at 2.77/2.76/2.73/2.72 ppm, and an aliphatic triplet
with signals at 1.22/1.20/1.18 ppm. These signals are attributed to H1, H2, H3, and H4, respectively.
The observed integration of these signals is 1:1:2:3.
Like that of 1, upon coordination to Mg2+, the proton signals attributed to the ethylmaltol
ligand exhibit a consistent splitting pattern: two aromatic doublets at 7.95/7.94 ppm and 6.45/6.43
ppm, an aliphatic quartet with signals at 2.77/2.75/2.73/2.71 ppm, and an aliphatic triplet with
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signals at 1.20/1.18/1.16 ppm. Additionally, these signals are unilaterally upfield shifted and the
integration is conserved (Figure 13).

Figure 12. Full 1H NMR of the ethylmaltol ligand with insets indicating the enhanced
aromatic region (left) and the enhanced aliphatic region (right) to display chemical
shifting and integration. NMR was conducted in D2O.

Upfield shifting was 0.01ppm, 0.01ppm, 0.01ppm, and 0.01ppm for H1 – H4, respectively.
As was noted of 1, conserved integration and upfield shifting are consistent with ethylmaltol
coordination to Mg2+ devoid of the formation of new signals that would indicate secondary side
reactions. The 1H NMR signals are attributed to H1, H2, H3, and H4, respectively. 1H NMR analysis
of 2 also exhibited a quartet with peaks between 2.51 – 2.72 ppm, which is attributed to magnesium
citrate (Figure 14). Presence of magnesium citrate was confirmed via 1H NMR and is the result of
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utilizing citric acid to solubilize the magnesium oxide starting material. The integration of the
peaks attributed to magnesium citrate indicate a percent composition of 6.1%.

Figure 13. Full 1H NMR of 2 with insets indicating the enhanced aromatic region (left) and the
enhanced aliphatic region (right) to displaying chemical shifting and integration. NMR was
conducted in D2O.

Figure 14. 1H NMR Overlay of ethylmaltol (top) and 2 (bottom) indicating the observed shifting
of ethylmaltol proton signals upon Mg2+ coordination. NMR was conducted in D2O.
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2.3.2. Confirmation of 2 Proton and Carbon Signal Determination Utilizing HSQC
and HMBC
As for 2, 2D 1H/13C HSQC and HMBC was again employed to confirm all proton and
carbon assignments for the ethylmaltol chelate analog. Considering the addition of only a methyl
spacer to the side chain, resulting in two saturated carbons and an additional aliphatic proton, two
signals were now expected on the HSQC spectrum.

Figure 15. Full 1H/13C HSQC NMR of ethylmaltol with signals zoomed for
clarity (inset bottom left). NMR was conducted in D2O.
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As predicted, two signals are observed (Figure 15). The assignments of the carbon signals
are relatively easy given that each proton has only one carbon within a single bond distance. As
such the carbon signal at 9.99 ppm is assigned as C7, and the carbon signal at 21.52 ppm is assigned
as C6.

Figure 16. Full 1H/13C HMBC NMR of ethylmaltol with the aromatic (inset bottom right)
and aliphatic (inset top right) regions highlighted for clarity. NMR was conducted in D2O.

The assignment of all carbon signals via HMBC was more elaborate, however, as a total
of ten signals were observed in a ratio of 4:3:2:1 for H1 – H4, respectively (Figure 16).
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Employing the same logic as before, all carbons were assigned with C1 at 178.60 ppm, and
C3, C4, C5, and C2 at 158.10 ppm, 154.90 ppm, 141.40 ppm, and 111.20 ppm, respectively. Given
the determined coordination mode of maltol, and the structural similarity to ethylmaltol, particular
interest was given to the C1, C2, and C5 carbon assignments.
Sol

Figure 17. Full 1H/13C HSQC NMR of 2 with signals zoomed (inset bottom left)
for clarity. NMR was conducted in D2O.

The HSQC and HMBC of Ethylmaltol were compared to 2 in the same fashion as the maltol
and Mg2+-maltol pair. Similarly, there was minimal difference between the HSQC of ethylmaltol
and Mg2+-ethylmaltol (Figure 17). Like the HSQC of ethylmaltol, the HSQC of Mg2+-ethylmaltol
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also exhibited two signals, suggesting no change to these protons or carbons, as expected given no
presence of Lewis bases for coordinative participation.

Figure 18. Full 1H/13C HMBC NMR of 2 showing both the aromatic (inset bottom right) and
aliphatic (inset top right) regions for clarity. NMR was conducted in D2O.
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There was, however, a substantial difference in the respective HMBC spectra of ethylmaltol and
2 (Figure 18); most notably, as was the case with 1, the disappearance of the interaction between
H1 and C5, and a substantial decrease in the C1 and C2 carbon signal intensity. Given no change in
proton signal assignment, this could only be the result of changes in carbon environment, and as
such, 13C NMR was utilized to confirm the coordination mode of ethylmaltol.
2.3.3. Characterization of 2 Via 13C NMR
The

13

observed, the

C NMR spectra of ethylmaltol was predicted to exhibit seven carbon signals. As
13

C NMR spectra of ethylmaltol exhibited seven carbons: two sp3-hybridized

saturated carbons and five carbons within the region attributed to C=O carbons and C=C carbons
(Figure 19 and Figure 20).

Figure 19. Full 13C NMR of ethylmaltol. NMR was conducted in D2O.
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The carbon environments of interest were the C1, C2, and C5 environments noted at 175.46
ppm, 113.28 ppm, and 141.19 ppm, respectively. These carbons were of interest given the
predicted bidentate coordination mode about the terminal alcohol and ketone, as was observed for
1.

Figure 20. 13C NMR overlay of ethylmaltol (top) and 2 (bottom). *Indicates peaks
attributed to magnesium citrate. NMR was conducted in D2O.

Like that of the 13C NMR of 1, the 13C NMR of 2 exhibited a change in the expected carbon
signals (Figure 20). Most notable, is a substantial decrease in the signal intensity of C1 and C2, as
well as a complete disappearance of C5 signal. These observations are consistent with coordination
about the ketone and the terminal acid, as was similarly deduced as the coordination mode of
maltol to Mg2+.
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2.4. NMR Characterization of HG2 and 3
2.4.1. 1H NMR Characterization of HG2 and 3
The 1H NMR spectrum of HG2 (Figure 21) exhibited two proton signals with a combined
integration of four in a ratio of 2:2; the observed signals were a sharp singlet at 3.84ppm (H1) and
a doublet centered around 3.80ppm (H2).

Figure 21. 1H NMR of HG2 exhibiting two proton signals in the aliphatic
region. Aliphatic region is enlarged for clarity (inset right). NMR was
conducted in D2O.
Additionally, the 1H NMR of 3 exhibited a combined integration of four. These
observations were consistent with the hypothesized observations. Like the 1H NMR spectrum of
HG2, spectral analysis 3 exhibited two proton signals with a combined integration of four (Figure
22). Unlike HG2, the observed proton signals of 2 were both singlets, and each singlet exhibited a
substantial upfield shift: H1 = 3.38ppm (Δppm = 0.46) and H2 = 3.76 (Δppm = 0.04) (Figure 22
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and Figure 23). Furthermore, spectral analysis of 2 revealed a quartet between 2.50 – 2.70ppm
attributed to magnesium citrate via 1H NMR, which is a result of citric acid utilization during
synthesis.

Figure 22. Full 1H NMR of 3 exhibiting two singlets in the aliphatic region. Aliphatic
region is enlarged for clarity (inset left). NMR was conducted in D2O. * indicates
signals attributed to magnesium citrate.
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Figure 23. Full 1H NMR overlay of HG2 and 3. NMR was conducted in D2O. *
indicates signals attributed to magnesium citrate.
2.4.2. Confirmation of 3 Proton and Carbon Signal Determination Utilizing HSQC
and HMBC
The HSQC spectrum of HG2 (Figure 24) indicated two correlation points: one point
attributed to H1 and one point attributed to H2. The point attributed to H1 corresponded to the carbon
signal at 40.7ppm, confirming this to be C1, and the point attributed to H2 corresponded to the
carbon signal at 43.4ppm, confirming this carbon to be C3.
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Figure 24. Full 2D 1H/13C HSQC of HG2 with signals zoomed for clarity.
NMR was conducted in D2O.

The HMBC of HG2 (Figure 25) showed three correspondence points of ratio 1:2. The
proton signal attributed to H2 exhibited two correspondence points. Given that H1 is within range
of only one carbon, this indicates that the observed correspondence point for H1 at 167.1ppm is
attributed to C2. Additionally, H2 shows two correspondence points. Given that the C2 carbon signal
corresponds to two protons, this confirms the assignment of the C2 proton given its proximity to
both protons, and the remaining carbon signal at 176.5 ppm is confirmed as C4 given that it is out
of range of the H1 proton (Figure 25).
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Figure 25. Full 1H/13C HMBC NMR of HG2. Signals are zoomed
for clarity. NMR was conducted in D2O.

HSQC analysis of 3 (Figure 26) indicated two correspondence points, like that of the HG2
ligand (Figure 23). Unlike the HSQC of HG2, both correspondence points are observed after 40
ppm (43.2 ppm and 43.7 ppm, respectively). The signal at 43.2 ppm is attributed to the C3 carbon
and the signal at 43.7 ppm is attributed to the C1 carbon. The substantial downfield shifting of the
C1 carbon supports coordination of the HG2 ligand via the amine – this is consistent with the proton
shift of H1 observed in the proton NMR spectrum of 3 relative to HG2.
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Figure 26. Full 1H/13C HSQC NMR of 3. Signals are zoomed for
clarity (inset bottom left). NMR was conducted in D2O.

In contrast to the HMBC of the free HG2 ligand, the ratio of correspondence points
observed for 3 is switched (2:1) (Figure 27). Given the observations made for the HMBC of HG2,
this indicates the more substantial upfield shift attributed to the H1 proton during 1H NMR analysis
is consistent with terminal amine participation in coordination. Additionally, the HMBC confirms
the H2 assignment and implicates the terminal carboxylic acid moiety, which was previously
supported by infrared analysis.
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Figure 27. Full 1H/13C HMBC NMR of 3. Signals are zoomed
for clarity (see inset). NMR was conducted in D2O.

2.4.3 Characterization of 3 Via 13C NMR
13

C NMR was conducted with the aim of confirming the conclusions derived from infrared

and 1H NMR analyses. The 13C NMR of 3 was conducted relative to HG2. Spectral analysis HG2
(Figure 28) revealed four (4) carbon signals: two signals between the range of 40 – 50ppm
attributed to the sp3-hybridized R-CH2-R carbon moieties (C1 – 40.7ppm, C3 – 43.4ppm) and two
signals between 160 – 180ppm attributed to the sp2-hybridized R-CO-R moieties (C2 – 167.1ppm,
C4 – 176.4ppm).
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Figure 28. Full 13C NMR of HG2. NMR was conducted in D2O.

13

C NMR analysis of 3 exhibited four (4) carbon signals in the same regions as HG2 (Figure

29). In contrast to the 13C spectrum of HG2, the signal separation was substantially diminished, a
result of the downfield shift of the C1 (Δppm = 3) and C2 (Δppm = 8) signals to 43.2ppm and
175ppm, respectively. These observations are consistent with those reported by Drevenṧek et al.8
and Chang et al.10 during their studies of magnesium testosterone and magnesium
ofloxacin/levofloxacin, respectively, and are consistent with magnesium coordination in regions
adjacent to these moieties. Additionally, in agreement with 1H NMR analysis, 13C NMR analysis
of 3 exhibited four signals attributed to magnesium citrate (Figures 29 and Figure 30) and no new
ligand-based carbon signals were observed, further supporting the formation of 3 as a 1:1 complex.
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Figure 29. Full 13C NMR Overlay of HG2 and 3. NMR was conducted in D2O. *
Indicates peaks attributed to magnesium citrate.

Figure 30. Full 13C NMR Overlay of HG2 (top) and 3 (bottom) with ketone carbon (left) and
saturated carbon (right) regions zoomed for clarity. NMR was conducted in D2O. * Indicates
peaks attributed to magnesium citrate.
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2.5. NMR Characterization of HG3 and 4
2.5.1. 1H NMR Characterization of HG3 and 4
The HG3 ligand exhibited three aliphatic singlets at 4.04, 3.91 and 3.79 ppm. These signals
were attributed to H2, H1, and H3, respectively. The integration of the observed proton signals was
in a ratio of 2:2:2. These observations were consistent with those predicted (Figure 31).

Figure 31. Full 1H NMR of glycylglycylglycine (HG3). NMR was conducted in 6:1 H2O:D2O.

The 1H NMR of 4 exhibited three signals attributed to HG3 (Figure 32). The splitting of
these signals was the same as HG3, with three aliphatic singlets observed. However, unlike HG3
upon coordination to Mg2+, there was an observable upfield shift of all observed signals attributed
to the HG3 ligand. 4 exhibited three proton signals at 3.97, 3.75, 3.41, respectively, indicating a
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confirmed upfield shift of 0.5 ppm for H1, 0.1 ppm for H2, and 0.04 ppm for H3. Furthermore, there
was no observed change to the integration of the signals attributed to HG3 consistent with no
further reactions after the formation of 4.

Sol

Figure 32. Full 1H NMR of 4 with inset indicating the enhanced aliphatic region
(left) to display chemical shifting and integration. NMR was conducted in D2O.
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4

Figure 33. 1H NMR overlay of HG3 and 4 indicating the upfield shift of HG3
proton signals as well as the conserved integration. NMR was conducted in D2O.

Given the more substantial upfield shift of the H1 proton suggests coordination to the terminal
amine (Figure 33). However, provided the established hard acid-base chemistry of magnesium, it
is more likely for Mg2+ to coordinate to the terminal acid. As such, the participation of the terminal
acid moiety in Mg2+ coordination was probed.
The 1H NMR of both HG3 and 4 was conducted in deuterated dimethyl sulfoxide (DMSOd6) to evaluate the participation of the terminal carboxylic acid in Mg2+ coordination. The 1H NMR
of HG3 in DMSO exhibited three aliphatic proton signals: two singlets and one double with signals
at 4.00, 3.85, and 3.75/3.74 ppm attributed to H2, H1, and H3, respectively. Given the tendency of
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polar aprotic solvents such as DMSO to participate in hydrogen bonding, there is an observed
splitting of the H3 signal nearest the terminal carboxylic acid, which is consistent with DMSO
hydrogen bonding to the protonated terminal acid thus resulting in an unequal distribution of
electron density about the acid that manifests itself in the observed doublet splitting of the H3
proton.
When analyzing the 1H NMR of 4 in DMSO-d6 (Figure 34), no splitting of the H3 proton
was observed, indicating the deprotonation of the terminal acid. Additionally, this indicates that
the now deprotonated G3- ligand has coordinated to Mg2+ about the terminal acid moiety, whose
electropositive character stabilizes the electron distribution resulting in no observed proton signal
splitting.

Figure 34. 1H NMR of HG3 (left) and 4 (right) in DMSO-d6 at equimolar
concentration.
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1

H NMR analysis of 4 is consistent with the deprotonated G3- coordinating via both the

terminal amine and the deprotonated terminal acid. It is, however, unlikely for the deprotonated
G3- to form a 10-membered ring structure and as such it is likely that either the backbone ketone
moieties or the backbone amides are also participating in coordination to Mg2+ and provide insight
into the formation of an entropically-favored tetradentate coordination mode. This is supported by
the work of Martell conducted in the 1950s and 60s, who theorized a tetradentate coordination
mode based upon titrimetric analyses.11,12 Further

13

C NMR studies were conducted to evaluate

the participation of the backbone ketone moieties.

2.5.2. Confirmation of 4 Proton and Carbon Signal Determination Utilizing HSQC
and HMBC
The HSQC spectrum of HG3 (Figure 35) exhibited only three correspondence points, with
each proton exhibiting only one correspondence to each carbon. Given the assignments of each
proton from the 1D 1H NMR, the subsequent assignment of each sp3-carbon was simplified. The
carbon exhibiting correspondence to the H1 proton was assigned as C1, the carbon corresponding
to the H2 proton signal was assigned as C3, and the carbon corresponding to the H3 proton was
assigned as C5 with the carbons exhibiting chemical shifts of 40.48, 42.35, and 43.18 ppm.
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Figure 35. Full 2D 1H/13C HSQC NMR of HG3 with zoomed sp3-hybridized carbons
highlighted in inset (bottom left).

The 2D 1H/13C HMBC NMR of HG3 (Figure 36) exhibited five correspondence points in
a ratio of 2:1:2 for H2, H1, and H3, respectively. H1 was predicted to exhibit correspondence with
only one ketone carbon given the presence of only one such carbon within a 2 – 3 bond distance.
The carbon correspondence point for H1 is observed at 167.77 ppm and is assigned as C2. This
assignment is further supported by a secondary correspondence of this carbon to H2, which is the
only other proton within distance of this carbon. The second correspondence point observed for
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H2 is at 170.79 ppm and is attributed to the C4 assignment. This assignment is corroborated by a
secondary correspondence exhibited by this carbon to the H3 proton – the only other proton within
distance of this carbon. The final correspondence point for H3 is observed at 176.36 ppm and is
attributed to C6. Given the predicted correspondence of the C6 carbon to only the H3 within
plausible distance, these observations are consistent.

Figure 36. Full 2D 1H/13C HMBC NMR of HG3 with the zoomed sp2-hybridized
region observed as the inset (bottom left).
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Upon Mg2+ coordination, there were observed changes to the correspondence points
attributed to the HG3 ligand of both the HSQC and HMBC spectra of 4.

Figure 37. Full 2D 1H/13C HSQC NMR of 4 with zoomed sp3-hybridized
carbons highlighted in inset (bottom left).
While only three correspondence points were observed like that of the HSQC of HG 3, the
correspondence points are no longer observed as a triangle, but more so as a straight line (Figure
37). Given the predicted coordination mode, the proton signals observed at 3.76, 3.53, and 3.21
ppm were assigned as H2, H3, and H1, respectively. The carbon signals observed at 42.36, 43.14,
and 43.51 ppm, were assigned C3, C5, and C1 as based upon there respective corresponding proton
signals. As such, C1 observes the most substantial shift in signal (Δ = 2.9 ppm). This observation
supports the coordination of the terminal amine moiety.
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2.5.3. Characterization of 4 Via 13C NMR
Mg2+ coordination to oxygen-containing moieties (e.g. ketones and carboxylic acids) has
been shown to result in a substantial impact to the observed carbon signals of the coordinate ligand
(i.e. signal intensity reduction or changes in signal resolution), as was the case for the magnesium
complexes of the steroids ofloxacin and levofloxacin.8 As such,

13

C NMR was utilized to

determine the participation of the backbone ketones of HG3 in Mg2+ coordination.
The 13C NMR of HG3 (Figure 38) exhibited six carbon signals: three sp2-hybridized carbon
signals at 176.48, 170.84, and 167.79 ppm, as well as three sp3-hybridized carbon signals at 43.18,
42.35, and 40.48 ppm. These carbon signals are attributed to C2, C4, C6, C5, C3, and C1,
respectively, and are consistent with the predicted six carbon signals expected. The sp3-hybridized
carbons are attributed to saturated backbone carbons. The sp2-hybridized carbons are attributed to
the terminal carboxylic acid and the backbone ketones, which are predicted to exhibit substantial
change upon coordination to Mg2+.
Comparatively, the 13C NMR of 4 (Figure 39) also exhibited six observed carbon signals
and showed a conserved three sp2-hybridized signals and three sp3-hybridized signals. Notably,
the 13C NMR spectrum of 4 exhibited a substantial shift of the C6 carbon assigned as the terminal
carboxylic acid which is consistent with the observations made for the 1H NMR and provides
further support for the participation of the terminal carboxylic acid in Mg2+ coordination.
Additionally, there is a substantial shift of the C1 carbon assigned as the carbon nearest the terminal
amine, which is also consistent with the observations made for the 1H NMR and provides further
support for the coordinative participation of this moiety (Figure 40).
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Figure 38. Full 13C NMR of HG3 indicating three sp2-hybridized carbons (inset
left) and three sp3-hybridized carbons (inset right). NMR was conducted in D2O.

Figure 39. Full 13C NMR of 4 exhibiting three sp2-hybridized carbon signals (inset left)
and three sp3-hybridized carbon signals (inset right). NMR conducted in D2O.
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Unexpectedly, there is little to no change of the C2 and C4 carbons, assigned to the backbone
ketones, which is consistent with no participation of these moieties in metal binding. Considering
the unlikelihood of the formation of a ten-membered ring structure, these observations provide
further support for a tetradentate coordination mode of the G3- ligand utilizing the backbone amine
moieties.
Lastly, the conservation of six carbon signals provides further support for the absence of
secondary reactions resulting in the formation of undesired products. This is again consistent with
the observations made for the 1H NMR of 4.

Figure 40. Full 13C NMR overlay of HG3 and 4 exhibiting three sp2-hybridized carbon
signals (inset left) and three sp3-hybridized carbon signals (inset right). NMR conducted in
D2O.
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2.6. Conclusion
A combination of 1D and 2D 1H/13C NMR provides ample insight into assumed
coordinative mode of a ligand when coordinating Mg2+. In general, ligand coordination to Mg2+
will result in an observable upfield shift of the protons nearest coordination sights with a
diminishing impact further away from the sight of coordination. Noticeably, amines are much more
susceptible to this observed shifting, relative to carboxylic acids, as was the case with 3 and 4.
This may be attributed to the less electron dense amine’s inability to accommodate the largely
electropositive character of Mg2+ like the more electron dense acid is able to do. Moreover, a
substantial shift of the adjacent amine protons is attributed to Mg2+ coordination about this moiety.
Furthermore, 1H NMR analysis in DMSO may be utilized to confirm the deprotonation of the
terminal acid and provide insight to the availability of this moiety for coordination, as was
observed for 4.
13

C NMR may be even more telling in terms of determining ligand coordination mode

given the impact that Mg2+ coordination can have on ketones. Consistent with previous findings,
Mg2+ coordination to ketone moieties will result in a substantial decrease in signal intensity, as
was the case with 1 and 2.
While Mg2+ coordinative manifestations are plentiful, determining all proton and carbon
identities is essential and 2D HSQC/HMBC are ideal for this purpose. The combination all types
of NMR analysis provides a reliable means of determining ligand coordination mode to Mg2+.
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Chapter 3. Determining Complex Composition and Varying Degrees of Mg2+-Complex
Hydration Utilizing Solid-State Analyses and Potentiometry
All work in this chapter was completed by the author unless otherwise indicated.
3.1 Introduction
While 1D and 2D NMR analysis is sufficient to determine the coordination mode of the
utilized ligands to Mg2+ in solution, it provides no means of elucidating the chemical structure of
the isolated Mg2+-complexes in the solid state. Solid-state analysis of the Mg2+-complexes was
employed not only to provide support for the coordination modes of the utilized ligands as
predicted from NMR analysis in the solution state, but also to determine the overall composition
of all isolated Mg2+ complexes. Solid-state analysis of Mg2+ complexes is, however, substantially
complicated by the innate chemical properties of Mg2+ itself.
Mg2+ will bind hydration water tighter than other biorelevant cations such as calcium
(Ca2+), sodium (Na+), and potassium (K+).1 As such, the hydrated radius of Mg2+ is approximately
400 times greater than the dehydrated Mg2+ radius, whereas the hydrated radius of Ca2+ is
approximately 25 times greater than that of its fully dehydrated radius. A similar
hydrated/dehydrated radius ratio is observed for Na+, while the hydrated radius of K+ is only ~4
times greater than its dehydrated radius.1
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Figure 3. Possible Mg2+-ligand coordination modes observed in solution.

The ability of Mg2+ to readily hydrate so extensively provides insight into the modes of
Mg2+ uptake and the requirement of claudins to facilitate transport through tight junctions (TJ), as
well as the different types of Mg2+ coordination modes in solution (Figure 1).2 The tendency of
Mg2+ to bind water so tightly further complicates Mg2+ dehydration1 and gives rise to Mg2+(L)x•
xH2O species, such as the magnesium citrate 14-hydrate complex extensively described in the
solid-state by Mansour et al.3
Given the complications in formulation brought about by Mg2+ hydration, we assayed for
the presence of water across complexes 1 – 4 via Fourier Transform Infrared (FT-IR) and thermal
analyses (thermogravimetric analysis (TGA)/differential scanning calorimetry (DSC)) to qualify
and quantify complex hydration. Compositional determinations supported by these findings were
further corroborated utilizing elemental analysis (EA). In the case of 1:1 Mg2+:monoanion
complexes (e.g., 3

and 4), compositional findings were supplemented with potentiometric

analyses to confirm required complex charge balance via hydroxide anion (OH-), which cannot be
singularly distinguished from waters of hydration via the other methods noted above.
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3.2. FT-IR Supports Ligand Coordination Modes and the Presence of Water
3.2.1. FT-IR Analysis of 1
The FT-IR spectrum of 1 was analyzed relative to the FT-IR spectrum of maltol. The FTIR spectrum of maltol was analyzed between 1500 – 1700 cm-1 and 3000 – 3500 cm-1 with peaks
of interest at 1621, 1655, and 3260 cm-1 – these peaks were attributed to the ketone and the terminal
alcohol, respectively. The FT-IR spectrum exhibited the almost complete disappearance of the
band attributed to the terminal alcohol and was observed at 3264 cm-1 and the ketone peaks were
observed at 1617 and 1655 cm-1, respectively (Figure 2).

Figure 4. Full FT-IR spectrum of maltol (blue)/1 (red) with the ketone fingerprint region enlarged
(inset) and signal assignments provided (table at right).

The observed change in the frequency of the signals attributed to the ketone moiety of 1 are
higher in energy relative to maltol,4 which is consistent with magnesium coordination about the
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ketone, and a shift to slightly higher energy is consistent with magnesium coordination as reported
by Nara et al.5 However, this is different than the signal shifts observed for other divalent metalmaltol complexes such as bismaltolato zinc (II),6 which exhibited shifts to lower energy. This may
be the result of zinc being less electropositive in character than magnesium, thus resulting in less
ionic character upon coordination, but may also be attributed to differences in ionic radii of the
two metals.
Strikingly, an intense, broad signal was observed at 3435 cm-1 (Figure 2) and qualitatively
confirms the presence of coordinated water, which is predicted from synthetic conditions and
agrees with the tendency of Mg2+ to take on water. Given the 2:1 stoichiometry of maltol to Mg2+,
charge balance is inherently provided by the ligand, mitigating the requirement of hydroxide anion
to zero.

3.2.2. FT-IR Analysis of 2
FT-IR analysis of the 2 complex was conducted relative to ethylmaltol (Figure 3) in a
method comparable to the analysis of the maltol/1 pair. The FT-IR spectrum of 2 (Figure 3) was
much more difficult to analyze given a lack of resolution and signal intensity in the fingerprint
region for the ketone, and thus was inconclusive in providing further support to the predicted
coordination mode of the ligand. However, there was an intense broad signal strikingly observed
at 3447 cm-1, which was again attributed to the presence of coordinated water. Given similarities
in reaction stoichiometry and ethylmaltol acting as a monoanion, it is again predicted that there is
no requirement for hydroxide to provide charge balance, and as such provides further support that
the attribution of this signal to coordinated water is correct.
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Figure 5. Full FT-IR spectrum of the ethylmaltol (blue)/2 (red) pair with the fingerprint region
for ketones enlarged (inset) and signal assignments provided (table at right).

3.2.3. FT-IR Analysis of 3
The FT-IR of 3 relative to HG2 exhibited a substantial change in the frequency region that
corresponds specifically to the −OH stretching mode attributed to the carboxylic acid of the HG2
ligand at 3287 cm−1. HG2 exhibited a sharp stretching band in this region that is not observed for
3, providing support for the deprotonation of the acid (pKa = 3.14). Additionally, HG2 exhibits a
broad signal at 2055 cm−1, which is attributed to the terminal amine (−NH3+), a signal not observed
for 3. This indicates that both the terminal amine and the terminal acid are in coordination. The
FT-IR spectra of HG2 and 3 are shown in Figure 4.
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Figure 6. FT-IR spectra of HG2 (blue) and 3 (red) conducted in KBr.
3.2.4. FT-IR Analysis of 4
Given a predicted tetradentate coordination mode of the HG3 ligand upon deprotonation of
the terminal acid, particular interest was paid to the region between 3000 – 3500 cm-1 as well as
the region between 900 – 1200 cm-1. Most notably, the FT-IR spectrum of HG3 (Figure 5) exhibited
a sharp, intense signal at 3297 cm-1 and a broader, less intense signal at 2635 cm-1, which were
attributed to the terminal carboxylic acid. After reacting with Mg2+, the signals at 3297 cm-1 and
2635 cm-1 were no longer observed and provided support for the predicted deprotonation of the
terminal acid. Evidence of the coordination of the anionic G3- ligand to Mg2+ via the deprotonated
acid is provided by the observable shift of the C-O signal for the unreacted HG3 ligand observed
at 991 cm-1 and the same signal of 4 shifted (Δcm-1 = 37) to lower energy observed at 1028 cm-1
(Figure 5).
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Figure 7. Full FT-IR spectrum of HG3 (red) and 4 (blue) including
signals of interested (table at top right).
Also, of interest was the intense, broad signal at ~3050 cm-1 observed for 4 which was
again attributed to coordinated water. Provided the monoanionic G3- ligand was reacted with Mg2+
in a 1:1 stoichiometry, it was predicted that the isolated solid achieved charge balance via a
hydroxy anion, which was subsequently confirmed via potentiometric analysis.

3.3. Determining the Composition of Complexes 1 – 4
3.3.1 Determining the Composition of 1
3.3.1.1. Thermal and Elemental Analyses of 1
Maltol exhibited a continuous percent weight loss onset at ~ 70°C to 200°C and stopped
decreasing in percent weight at approximately 5% (Figure 7), thus suggesting decomposition of
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maltol between 160 and 200°C, which is consistent with the known melting point of maltol at
160°C.7

Figure 8. Thermal analyses of 1 with maltol TGA (green),
Mg2+-maltol TGA (red) and 1 DSC (blue).

TGA analysis of 1 exhibited a similar decomposition trend differing only with the percent
weight loss exhibited by 1 reaching a minimum at approximately 40%. The DSC spectrum of 2
exhibited two endotherms: a broad endotherm with an apex at approximately 120°C attributed to
the loss of coordinated water from 1, and a secondary more intense, sharper endotherm attaining
apogee at approximately 160°C. This endotherm is attributed to the thermal decomposition of the
maltol ligand (Figure 6), which is consistent with the TGA of maltol. The endotherm at 120°C
corresponds to a percent weight decrease of 22.70% observed on the TGA of 1, which is attributed
to the loss of four water molecules given a predicted percent weight change of 20.80%. While the
EA of 1 suggests only three waters with values of {[Mg(C6H5O3)2(H2O)2].H2O}: C = 43.17%, H
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= 4.75%; Exp: C = 43.33%, H = 4.49%, this difference is attributed to different hydrated states
given the propensity of magnesium to take on water.2,3 The composition of 1, including the
presence of waters was supported by EA analyses, which indicated the presence of three waters.
While thermal analyses indicated an additional water, this is easily attributed to differences in
hydrated states.

3.3.1.2. Mass Spectrometry Supports the Mg2+:Maltol Stoichiometry of 1

Figure 9. Mass spectrum of 1. ESI-MS conducted in 50/50 MeOH/H2O.

ESI-MS of 1 exhibits two signals at 127 m/z and 306 m/z, respectively (Figure 7). The
signal observed at 127 m/z is attributed to maltol and the signal at 306 m/z is attributed to the
methanol adduct of a 1:2 Mg2+:maltol species. Observance of the signal at 306 m/z coincides with
the predicted stoichiometry as a result of synthetic conditions as well as the conclusions drawn
from thermal analyses of 1. This provides further confirmation of the hypothesized 1:2
Mg2+:Maltol stoichiometry of 1.
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3.3.1.3. Discussing the Core Structure of 1
The core structure of 1 is provided below as Figure 8. In general, Mg2+ assumes a sixcoordinate octahedral geometry,2 which is consistent with the predicted core structure.

Figure 10. Precited core structure of 1.
Provided the NMR analyses discussed in chapter 2, the deprotonated maltol act as a
bidentate ligand and coordinate via an O,O donor set about the deprotonated terminal alcohol and
the ketone. Compositional determination via thermal and elemental analyses, as well as
stoichiometric support from ESI-MS confirms a 1:2 Mg2+:maltol stoichiometry. Thermal and
elemental analysis confirm a rounded-out core structure consisting of two waters with excess
waters of hydration expected in varying degrees.

3.3.2. Determining the Composition of 2
3.3.2.2. Thermal and Elemental Analyses of 2
As observed with maltol, ethylmaltol exhibited only one continuous percent weight
decrease from approximately 70°C - 200°C and stops decreasing in weight at approximately 5%
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weight (Figure 9). This profile is attributed to the thermal decomposition of the ethylmaltol ligand,
which is predicted to be roughly the same as maltol at ~160°C.
The TGA of 2 differed to that of ethylmaltol in that it exhibited two distinguishable percent
weight decreases and stopped decreasing in percent weight at approximately 35%. Both percent
weight changes correspond to two separate endotherms observed on the DSC of Mg2+-ethylmaltol
– one broad endotherm apexed at approximately 110°C and a secondary sharp, and substantially
more intense, endotherm with an apex at approximately 320°C, respectively.

Figure 11. Thermal analyses of 2 with ethylmaltol TGA (green), TGA of 2 (red) and
the DSC of 2 (blue).

The first broad endotherm observed on the DSC of complex 2 shows a corresponding
percent weight change of 15.33%, which corresponds to the loss three waters from the overall
[Mg(EtMa)2(H2O)2]•H2O] complex supported by the EA with a predicted weight percent change
of 15.15%. The secondary, more intense, endotherm at approximately 320°C is attributed to the
decomposition of the ethylmaltol ligand. The number of waters observed for 2 via thermal analyses
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predict two waters directly coordinated to the magnesium core, and two additional waters of
crystallization. The presence of three waters is consistent with theoretical EA values for
{[Mg(C7H7O3)2(H2O)2].H2O}: C = 46.32%, H = 5.47%; Exp: C = 46.95%, H = 5.05%. However,
magnesium readily absorbs water and differing drying conditions and/or sample preparations
likely have contributed to the different hydration states noted.2 The three waters observed for 2
support two coordinated waters and one water of crystallization.

3.3.2.3. Mass Spectrometry Supports the Mg2+:Ethylmaltol Stoichiometry of 2

Figure 12. Mass spectrum of 2. ESI-MS conducted in 50/50 MeOH/H2O.

Similar to the mass spectrum of 1, ESI-MS analysis of 2 exhibited two peaks at 141 m/z
and 334 m/z, respectively (Figure 10). The signal observed at 141 m/z is attributed to ethylmaltol
and the signal observed at 334 m/z is attributed to the methanol adduct of a 1:2 Mg2+:ethylmaltol
species. This is again consistent with the predicted 1:2 Mg2+:ethylmaltol stoichiometry as based
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upon synthetic conditions, as well as the conclusions drawn from thermal analyses of 2. This
provides further confirmation of the hypothesized 1:2 Mg2+:ethylmaltol stoichiometry of 1.

3.3.2.3. Discussing the Core Structure of 2
The core structure of 2 is provided below as Figure 11. In general, Mg2+ assumes a sixcoordinate octahedral geometry,2 which is consistent with the predicted core structure.

Figure 13. Predicted core structure of 2.

Like 1, NMR analysis of 2 (see chapter 2) indicates an O,O bidentate coordination mode
of ethylmaltol via the deprotonated terminal alcohol and the ketone. Thermal analyses, as well as
ESI-MS, support a 1:2 Mg2+:ethylmaltol stoichiometry. Given the monoanionic character of
ethylmaltol and the predicted stoichiometry, 2 retains charge balance via ethylmaltol coordination.
Additionally, thermal and elemental analyses, indicate that the remaining two Mg2+ coordination
sites available are occupied by water with additional waters of hydration expected and observed.
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3.3.3. Determining the Composition of 3
3.3.3.1. Thermal and Elemental Analyses of 3
TGA of HG2 exhibited a single, gradual percent weight decrease onset at 220°C
(inflection point observed at 270°C), which is consistent with the melting point of HG2 at 220°C.
TGA analysis of 3 indicated a gradual decline in percent weight onset from 30°C until just before
200°C. The weight change accounts for a loss of 21%, which is consistent with the loss of 2 waters
(calculated to 19%) (Figure 12). This result is consistent with the tendency of magnesium to take
on water in a rapid fashion.2,3 Thus suggesting a core magnesium species of Mg(G2)(H2O)(OH),
where rapid acquisition of subsequent water molecules is likely.

Figure 14. Overlay of HG2 TGA (green) and TGA of 3 (red).
The presence of two waters for 3 via thermal is consistent with ICP analysis of 3, which was
consistent with a species of composition Mg(G2)(H2O)(OH) × 5 H2O, with theoretical nitrogen
and magnesium values of Mg = 8.66% and N = 9.99% compared to experimental values of Mg
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= 8.78% and N = 9.89%. Utilizing the Mg:N ratio, the experimental ratio of M:N = 0.89 and is
consistent with the theoretical value of Mg:N = 0.87.

3.3.3.2. Mass Spectrometry Supports the Mg2+:HG2 Stoichiometry of 3
The mass spectrum of 3 exhibited several signals of note. Most notable are the signals
observed at 155 m/z and 210 m/z, respectively (Figure 13). The signal at 155 is attributed to a 1:1
Mg2+:G2 species and the signal at 210 m/z is attributed to a trihydrate 1:1 Mg2+:G2-1 species. Both
species are consistent with the predicted 1:1 Mg2+:G2 species, and the presence of the trihydrate
species is consistent with Mg2+ water affinity.1 These observations are consistent with the
observations made for the thermal analysis of 3 and are consistent with the determined 1:1
Mg2+:G2- complex composition.

Figure 15. Mass spectrum of 3. ESI-MS conducted in 50/50 MeOH/H2O.

84

3.3.3.3. Discussing the Core Structure of 3

Figure 16. HG2 (left) and the predicted core structure of 3 (right).
The predicted structure of 3 is provided as Figure 14. Provided the NMR analyses
conducted on 3, it is predicted that the deprotonated G2- ligand acts in a tridentate fashion and
coordinates via an N2O donor set utilizing the terminal amine, backbone amide, and deprotonated
terminal acid. The predicted 1:1 Mg2+:G2- stoichiometry of 3 is confirmed via thermal analyses
and ESI-MS. Compositionally, thermal and elemental analyses confirm the presence of three
waters, which is confirmed as two waters and a hydroxide anion, which was confirmed via
potentiometric measurements – the hydroxide is required for complex charge balance given the
presence of only one monoanionic G2-. Excess waters of hydration are expected upon sample
analysis.
3.3.4. Determining the Composition of 4
3.3.4.1. Thermal and Elemental Analyses of 4
It was hypothesized that the two coordination sites of the magnesium remaining
beyond the HG3 ligand donor set (N3O) would be occupied by water, while charge balance would
be achieved via a hydroxy anion.
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Figure 17. Thermal analyses of 4 with HG3 TGA (green), TGA of 4 (red) and DSC
of 4 (blue).

The TGA of 4 was strikingly different than that of HG3, which exhibited only one
continuous weight percent change beginning at approximately 240 °C (Figure 15). 4 exhibited
three weight percent changes: 6.6% at 109 °C, 14.1% at 191.5 °C, and one continuous change at
approximately 240 °C. The first weight percent change corresponds to loss of a hydroxy anion—
further validated by conductivity which showed a monoanionic character of 4. The second weight
percent change corresponds to the loss of two coordinating waters from a parent complex of
[Mg(G31-)(H2O)2]OH, and the last corresponds to the degradation of HG3. These three independent
events were further supported by the presence of three separate observable endotherms on the DSC
at ~109, 191 and 240 °C (Figure 15). Elemental analysis values for 4 confirmed the presence of
two waters and a hydroxide theoretical values of C = 29.00%, H = 5.68%, N = 16.90% and
experimental values are of C = 29.22%, H = 6.22%, N = 16.03%. Differentiation between an
additional water or a hydroxide was probed utilizing potentiometric analyses which indicated that
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4 exhibited a potential less than that observed for a KCl standard that acts as a 1:1 electrolyte. This
supports that 4 achieves charge balance with a hydroxide and acts as a salt given this presence.

3.3.4.2. Mass Spectrometry Supports Mg2+:HG3 Stoichiometry of 4

Figure 18. Mass spectrum of 4. ESI-MS conducted in 50/50 MeOH/H2O.

The mass spectrum of 4 exhibited three signals of interest at 190 m/z, 230 m/z, and 252
m/z, respectively (Figure 13). These signals are attributed to the HG3 ligand, a 1:1 Mg2+:G31monohydrate species, and the sodium adduct of the monohydrate species, respectively. All species
coincide with the predicted 1:1 Mg2+:G31- species and are consistent with the conclusions drawn
from thermal analyses of 4. These results further support an overall 1:1 Mg2+:G31- complex
stoichiometry.
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3.3.4.3. Discussing the Core Structure of 4
The predicted structure of 4 is provided as Figure 17. As shown, 4 consists of a 1:1
Mg2+:G31- stoichiometry which is supported by both thermal analyses and ESI-MS. Additionally,
thermal analyses are consistent with the presented number of waters. Similar to 3, 4 exhibits the
G3- ligand acting in an entropically-favored tetradentate fashion utilizing an N3O donor set. 4
exhibits an octahedral coordination sphere that is completed by two coordinating waters. Given
only one monoanionic G3- ligand, charge balance is achieved via a hydroxy anion, the presence of
which was determined via potentiometry. It is possible, that the hydroxide anion is coordinated,
but is unlikely given the affinity for water of Mg2+. It is expected that excess waters of hydration
will be observed.

Figure 19. HG3 (left) and the predicted core structure of 4 (right).
3.4. Conclusion
Compositional analyses of 1 – 4 supplement solution-state analyses, which determine only
ligand coordination, by confirming complex composition and Mg2+:ligand stoichiometry. In the
case of 1 and 2, both maltol and ethylmaltol act as bidentate ligands via an O,O donor set utilizing
the deprotonated terminal alcohol and the ketone. Additionally, both complexes exhibited a sixcoordinate octahedral coordination sphere completed by a minimum of two coordinated waters as
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confirmed via thermal and elemental analyses. Provided the confirmed 1:2 Mg2+maltol/ethylmaltol
stoichiometry, 1 and 2 achieve charge balance solely via maltol and ethylmaltol coordination.
3 and 4 were determined to exist in a 1:1 Mg2+:G2-/G3- stoichiometry. As expected, both 3
and 4 observed the G2- ligand acting as a tridentate ligand and the G3- acting in a tetradentate
fashion via an N2O and N3O donor set, respectively. Given the presence of only one monoanion,
both complexes achieve charge balance via a hydroxide anion and act as 1:1 electrolytes in
solution. As was expected for all complexes, access waters of hydration were observed and are
consistent with the tendency of Mg2+ to rapidly take on water.1
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Chapter 4. Evaluating the Solubility and In Vitro Cellular Uptake of 1 – 4 in Colorectal
Carcinoma (CaCo-2) Cells
All work in this chapter was completed by the author. Work in this chapter was published in:
•
•

Case, D. R.; Gonzalez, R.; Zubieta, J.; Doyle, R. P. Synthesis, Characterization, and
Cellular Uptake of a Glycylglycine Chelate of Magnesium. ACS Omega. Published
ahead of print online 11/30/2021 DOI: 10.1021/acsomega.1c04146.
Case, D. R.; Gonzalez, R.; Zubieta, J.; Doyle, R. P. Synthesis, Characterization, and
Cellular Uptake of Magnesium Maltol and Ethylmaltol Complexes. ACS Omega 2021, 6
(44), 29713-29723.

4.1 Introduction
As more comprehensively described in Chapter 1, the majority of Mg2+ uptake occurs in
the GI, with the majority of uptake occurring in the jejunum1,2, and varying degrees of uptake
occurring unequally throughout the length of the GI.1,2
It us generally accepted in the nutraceutical field that the greater the %Mg composition of
a supplement, the greater will be the uptake, irrespective of solubility. This is observed
prominently via the administration of magnesium oxide as one of the most ubiquitously used Mg2+
supplement, with some 60% Mg2+ composition but low solubility in water (0.010 g/100 mL)3,4
There has been, however, in reality a real dearth of attention given to Mg2+ uptake as it specifically
relates to complex solubility, with interest growing in recent years.5–7 with most studies comparing
different formulations of magnesium oxide to each other,8 magnesium oxide to magnesium
citrate,9 and small studies of magnesium oxide to other organic magnesium formulations, such as
those conducted by Uysal et al.3 and Kappeler et al.7
To this end, the aim of evaluating the in vitro cell uptake was to analyze uptake relative to
complex solubility for 1 – 4 (fully described in chapters 2 and 3) with the intention of providing
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more comprehensive support for increasing Mg2+ bioavailability relative to increasing complex
solubility.

4.2. Aqueous Solubility and In Vitro Uptake of 1 – 4
4.2.1. Determining the Aqueous Solubility of 1 – 4
The water solubility of complexes 1 – 4 is shown in Table 1. In general, complexation of
coordinate ligands to Mg2+ results in an increase in overall solubility. This may be due, in part, to
the affinity that Mg2+ has for water.1 Additionally, in the case of diglycine and triglycine, this could
be attributed to an increased salting-in effect as a result of increased solution ionic strength in the
presence of cationic Mg2+.12 As noted for 1 and 2, the trend for solubility is conserved with 2
exhibiting greater solubility than 1, much like ethylmaltol exhibits greater solubility than maltol.
Interestingly, 4 exhibits more substantial water solubility than 2 even though diglycine retains
greater water solubility than triglycine. This may be attributed to a more extensive hydrogen bond
network exhibited by triglycine, as highlighted by Srikrishnan et al.,15 relative to diglycine.

Complex Name

Molecular
Weight (g/mol)

Formula

%Mg in
Compound

Solubility
(g/100mL)

Ligand Solubility
(g/100mL)

Magnesium Chloride

203.3

MgCl2•6H2O

11.9

54

--

MgO

40.3

MgO

60.3

0.010

--

1

310.5

Mg(C6H5O2)2(H2O)2 • xH2O

7.8

15.6 ± 1.17

1.210

2

338.6

Mg(C7H7O3)2(H2O)2 • xH2O

7.2

16.2 ± 0.75

5.8411

3

191.5

Mg(G2)(H2O)(OH) • xH2O

17.3

39.40 ±2.84

22.812

4

265.5

[Mg(G3)(H2O)2]OH

9

169 ± 12.5

6.4 – 6.913,14

Table 1. Aqueous solubilities of 1 - 4.
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4.2.2. Determining the In Vitro Cell Uptake of 1 – 4 in CaCo-2 Cells
4.2.2.1. Determining the Uptake of 1 and 2
The uptake of 1 and 2 was evaluated relative to MgCl2, and done so with the understanding
that the complexes contained ~6 – 7% magnesium citrate, respectively, and the concentrations are
based upon a total concentration of magnesium contributed from both species as based upon
molecular weight. The uptake of Mg2+ from 1 and 2 was substantial and complex 2 exhibited
slightly greater Mg2+ uptake relative to 1 although containing less overall Mg2+ (7.2% versus 7.8%,
respectively) (Figure 1). It should be noted, however, that the uptake exhibited by 1 and 2 is
relatively similar, as is expected given similarities in solubility and percent Mg 2+ composition.
Strikingly, however, both 1 and 2 exhibit greater overall uptake than MgCl2.

Figure 20. Cellular uptake of MgCl2, 1, and 2 in CaCo-2 cells. Slope/R2 MgCl2: 5x10-5/0.7373.
Slope/R2 1: 0.0001/0.8198. Slope/R2 2:0.0001/0.8433. SEM: MgCl2 = ±0.0006, 1 = ±0.001, 2
= ±0.001; Upper 95% C.I.: MgCl2 = 0.004, 1 = 0.008, 2 = 0.011; Lower 95% C.I. = MgCl2 =
0.001, 1 = 0.001, 2 = 0.001).
4.2.3.1. Determining the Uptake of 3 and 4
Cellular uptake of 3 and 4 was also evaluated relative to MgCl2. Additionally, uptake of
magnesium bisglycinate (MgBG – the 1:2 (Mg2+:glycine) Mg2+-complex of the glycine monomer)
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was incorporated to provide insight into the impact that peptide length has one uptake as well.
Uptake is plotted as a linear regression (Figure 2).

Figure 21. Cellular uptake of 3 (orange) plotted with Magesium Bisglycinate (red), 4 (green) and
MgCl2 (Blue) in CaCo-2 cells. Slope/R2 MgCl2: 5x10-5/0.7373. Slope/R2 3: 5x10-4 /0.7231. Slope/R2
MgBG: 5x10-4/0.8477. Slope/R2 4: 7x10-4/0.8019. SEM: MgCl2 = 0.0006, MgBG = 0.0006, 3 =
0.0007, 4 = 0.001 ; Upper 95% C.I.: MgCl2 = 0.004, MgBG = 0.003, 3 = 0.004, 4 = 0.006 ; Lower 95%
C.I.: MgCl2 = 0.001, MgBG = 8.98x10-5, 3 = 1.11x10-5, 4 = 0.0005.
Analysis of cellular uptake data indicates that 3 exhibits uptake less than that of MgCl2 and
comparable to MgBG. Furthermore, observed uptake of 3 was only about half that of 4. The uptake
of 3 relative to MgBG is interesting because similarities. While 3 exhibits slightly greater uptake
than MgBG at higher concentration, it appears as though uptake is within error. That said, uptake
tentatively increases with increased peptide length from MgBG, 3, and 4. This observation is
relatively consistent with the uptake observed in humans for the free mono-, di- and tripeptide
glycine ligands observed by Craft et al.16 Craft explains that the rate of cellular uptake of the free
ligands is directly related to the available mole quantity of the ligand, and the corresponding rate
of uptake as it pertains to the amount of ligand available.16 It is believed that in the case of the
uptake of magnesium chelates of glycine-based complexes as reported, Craft’s discussion supports
the observable uptake trend. The trend of increasing uptake with a corresponding increase in
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peptide length is also supported by the findings of Hellier et al. who observed greater intestinal
absorption of HG2 relative to glycine in human studies.17
More interestingly, however, is that while uptake of the glycine oligopeptides seems to
trend in favor of increasing peptide length, relative to MgCl2, 1, and 2, the uptake of 3 and 4 is
substantially less, save for 4 exhibiting greater uptake than MgCl2 at higher concentrations. Given
only a minute presence of magnesium citrate, contributions from this species are negligible. While
solubility may explain the relationship between 4 and MgCl2, it does not explain why 1 and 2,
exhibiting substantially less water solubility exhibit substantially greater uptake.

4.4. Conclusions
The hypothesis that increased complex solubility corresponds to increased bioavailability
of Mg2+ was inconclusive. Complexes 1 and 2 exhibit the greatest Mg2+ uptake while retaining the
lowest complex solubility. Interestingly, however, when comparing only complexes 3 and 4,
uptake appears to increase with increasing peptide length. These findings are consistent with the
observed uptake for the free ligands. Additionally, the slope of uptake for 4 is substantially greater
than that for MgCl2, and at higher concentrations, 4 exhibits greater overall uptake than MgCl2.
While solubility may not be the main contributory factor, it must also be noted that percent Mg2+
composition is also not the main factor impacting Mg2+ uptake, as 1 and 2 also have the lowest
Mg2+ composition. Greater uptake of 1 and 2 relative to 3 and 4 may be attributed to the predicted
tri- and tetradentate coordination of 3 and 4, and only a bidentate coordination of 1 and 2. Increased
entropic stability of 3 and 4 may suggest greater uptake over a longer period relative to more
substantial uptake of 1 and 2 initially. Future in vitro studies are required to confirm these findings.
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Chapter 5. Experimental
5.1. Materials and Methods
5.1.1. Chemicals and Equipment
Laboratory grade chemicals and assorted solvents were purchased from Sigma Aldrich (St.
Louis, MO, USA), Fischer Scientific (Waltham, MA, USA), or Balchem Corp. (New Hampton,
NY). Both deionized and distilled water were provided in-house. When required, all centrifugation
of isolated synthetic compounds was conducted on a Sorvall RT instrument at a speed of 4000 rpm
for 10 min. Fourier Transform Infrared (FT-IR) was conducted on a Nicolet Infrared
Spectrophotometer utilizing a potassium bromide (KBr) pellet and typically scanned from 400 –
4000 cm-1. Thermogravimetric Analysis (TGA) was conducted in-house on a TA Instrument Q500
series (with the TGA of 3 conducted by the ThINC facility at Stoneybrook University
(Stoneybrook, NY, USA). Differential Scanning Calorimetry (DSC) was conducted on a TA
Instrument Q2000 series, respectively. Typical TGA analyses consisted of a 10°C/min ramp rate
on samples of 5 – 20 mg placed on a platinum pan and analyzed from 30 - 800°C. Typical DSC
analyses consisted of 5 – 10 mg samples crimped in T-zero aluminum pans scanned with a ramp
rate of 10°C/min from 30°C - 300°C. TGA and DSC spectral analysis was performed utilizing the
TA Instruments Universal Analysis 2000 software. Elemental Analyses (EA – C, H, N) and %Mg
composition were determined via inductively coupled plasma – optical emission spectrometry
(ICP-OES) analysis as necessary were conducted independently by Intertek Pharmaceutical
Services (Whitehouse, NJ, USA). Electrospray Ionization Mass Spectrometry (ESI-MS) was
conducted on a Shimadzu 8040 LC-MS/MS with samples typically analyzed from 100 – 600m/z
in a solvent system of 50/50 H2O/MeOH with 0.1% TFA. All Nuclear Magnetic Resonance (NMR)
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spectroscopy, both 1D- and 2D 1H/13C NMR (e.g. heteronuclear single quantum coherence
(HSQC) and heteronuclear multiple bond correlation (HMBC)) was carried out on a Bruker
Avance III HD 400 MHz instrument. Crystal data, when possible, were collected and refined by
Dr. William W. Brennessel at the X-Ray crystallographic center at the University of Rochester on
a Rigaku XtaLAB Synergy-S Dualflex diffractometer equipped with a HyPix-6000HE HPC area
detector.
5.1.2. Cell Lines and Culture Conditions
5.1.2.1. Colorectal Carcinoma (CaCo-2) Cells
The CaCo-2 cell line was purchased from ATCC (Manassas, VA, USA). CaCo-2 cells were
taken from liquid N2 stocks and rapidly thawed using a water bath at 37°C. Cryopreservation media
was removed with a micropipette after cells were pelleted via centrifugation for 2 min at 125g.
Cells were resuspended in 1mL of Dulbecco’s Modified Eagle Medium (DMEM) that had been
incubated at 37°C and cultured in DMEM (total volume of 5mLs) with a seeding density of 3.6x104
cells/cm2 in a T-25cm2 culture flask and left to grow in an incubator at 37°C and 5% CO2. When
cultures reached 90%+ confluency, cells were detached with manual scraping and gentle agitation,
and pipetted. Two T-25cm2 culturing flasks were combined and centrifuged into a pellet for 2min
at 125g – the old media was pipetted off and cells were resuspended in 11mL fresh DMEM. Cells
were plated in a 96-well plated at 100μL/well and left to grow to 90%+ confluency as to form a
monolayer. Plated cells were used to determine magnesium uptake.
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5.1.2.2. Mg2+ Uptake Assay
A colorimetric magnesium uptake assay kit for use with a 96-well plate was purchased
from BioVision (Milpitas, CA, US). Sample solutions for use with the kit were prepared in-house
utilizing magnesium/calcium free Hank’s Balanced Salt Solution (HBSS). The samples tested were
magnesium chloride hexahydrate (MgCl2•6H2O) and 1 – 4. The kit provided standard for linearity
confirmation begins as a 150nm/μl stock – as such MgCl2•6H2O, utilized as an internal standard,
was prepared at this concentration – containing 17.93mM Mg2+. Complexes 1 – 4 were prepared
to contain the same amount of Mg2+ as to evaluate Mg2+ uptake in a relative fashion. DMEM was
removed from the plated cells and cells were subsequently washed three times with HBSS in 100μl
volume. MgCl2•6H2O and 1 – 4 were administered at 150μl/well as triplicate independent
dilutions. Cells were treated for 1 – 2hr at 37°C and 5% CO2. After incubating, sample volume
was removed from each well and the cells were again washed three times with HBSS. Cells were
lysed utilizing 200μl/well of kit assay buffer, the post-lysis volume collected, and each sample
centrifuged at 14000g for 10 minutes. The resulting supernatants were replated in the same order
in 50μl volume. 50μl of kit-provided enzyme/buffer/developer mix was added to each well with a
multichannel micropipette, and the plate incubated for 40 minutes at 37°C. Some wells were left
blank for required background subtraction. The kit provided standard was diluted to 0, 3, 6, 9, 12,
and 15nmol/μl in DI H2O and administered and developed in the same volumes as MgCl2•6H2O
and 1 – 4 and was used only to determine kit linearity. Each well was analyzed for endpoint value
over nine full plate scans with triplet scans/well/plate scan (a total of 27 scans per well) and the
reported value of each well was the average value of these scans after background subtraction. All
samples were analyzed in triplicate. Data was collected at 40 minutes. Raw data was reduced and
plotted as absorbance against magnesium concentration of each well. All assays were repeated in
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triplicate (Slope/R2 MgCl2•6H2O: 5x10-5/0.7373. Slope/R2 1: 0.0001/0.8198. Slope/R2 2:
0.0001/0.8433. Slope/R2 3: 5x10-4 /0.7231. Slope/R2 4: 7x10-4/0.8019. SEM: MgCl2•6H2O =
±0.0006, 1 = ±0.001, 2 = ±0.001, 3 = 0.0006, 4 = 0.001; Upper 95% C.I.: MgCl2•6H2O = 0.004, 1
= 0.008, 2 = 0.011, 3 = 0.004, 4 = 0.006 ; Lower 95% C.I. = MgCl2 • 6H2O = 0.001, 1 = 0.001, 2
= 0.001, 3 = 1.11x10-5, 4 = 0.0005).

5.2. Syntheses
5.2.1. Synthesis of Magnesium Maltol (Mg(C6H5O3)2•xH2O) (1)
A 1.00g sample of maltol (7.93 mmol; 2 eq.) was dissolved in 10mLs of DI H2O in a 50mL
round-bottom flask, with constant stirring at 90°C. A separate solution of 192.2 mgs of magnesium
oxide (MgO – mmol; 1.2 eq.) was taken up in 10mLs of H2O, with an addition of 190.2 mgs of
citric acid (CA - 0.25 eq), constantly stirred and heated to 90°C. The MgO/CA solution was
subsequently added to the maltol solution in small increments over ~5 min. Upon addition, the
mixture was a translucent white color that solubilized in about 30 seconds; each subsequent
addition was administered when the previous addition had become wholly soluble. After all
additions, the reaction was noted as colorless and clear. The reaction was conducted for one hour,
whereupon the solution was noted as yellow and clear. The reaction was allowed to cool to room
temperature and the pH was noted as 7.80. The solution was dried in vacuo – producing a tan
solid, which was used for subsequent analyses. The yield of 1 was stoichiometric relative to maltol
with a purity of 92.8% based on 1H NMR. The solubility of 1 was determined to be 15.6 ± 1.17
g/100 mL H2O. 1H NMR (D2O, 400MHz): δ 4.79 (s, 1H), 7.95-7.94 (d, 1H, H2, J = 5.26Hz), 6.486.46 (d, 1H, H1, J = 5.38Hz), 2.33 (s, 1H, H3). EA: Theo for {[Mg(C6H5O3)2(H2O)2].H2O}: C =
43.17%, H = 4.75%; Exp: C = 43.33%, H = 4.49%.
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5.2.2. Synthesis of Magnesium Ethylmaltol (Mg(C7H7O3)2•xH2O) (2)
A 1.01g sample of ethylmaltol (EtMa – 7.14mmol; 2eq.) was dissolved in 10mLs of DI
H2O in a 50mL round-bottom flask, with constant stirring at 90°C. A separate solution of 158.6mgs
magnesium oxide (MgO – 3.93mmol; 1.1eq.) was taken up in 10mLs of DI H2O, with an addition
of 172.3mgs of citric acid (CA - 0.25eq), constantly stirred and heated to 90°C. The MgO/CA
solution was subsequently added to the ethylmaltol solution in small increments over 5 min. Upon
addition, the mixture was a translucent white color that solubilized in about 30 seconds; each
subsequent addition was administered when the previous addition had become wholly soluble.
After all additions, the reaction was noted as colorless and clear. The reaction was conducted for
one hour, whereupon the solution was noted as clear and amber/orange in color. The solution was
allowed to cool to room temperature and the pH was noted as 7.80. The solution was dried in
vacuo, at which time a tan solid was observed. The yield was found to be stoichiometric relative
to ethylmaltol, and the purity was 93.9% based on 1H NMR. The solubility of 2 was determined
to be 16.2 ± 0.75 g/100mL H2O. 2: 1H NMR (D2O, 400MHz): δ 4.79 (s, 1H), 7.99-7.98 (d, 1H,
H1, J = 5.26Hz), 6.48-6.47 (d, 1H, H2, J = 5.50Hz), 2.76-2.71 (q, 2H, H3, J1 = 22.62Hz, J2 =
7.70Hz), 1.19-1.15 (t, 3H, H4, J = 15.16Hz). EA: Theo for {[Mg(C7H7O3)2(H2O)2].H2O}: C =
46.32%, H = 5.47%; Exp: C = 46.95%, H = 5.05%.

5.2.3. Synthesis of Magnesium Glycylglycine (Mg(C4H7N2O3)(H2O)2(OH)) (3)
Glycylglycine (HG2) (1.02 g, 7.57 mmol) was dissolved in DI H2O (~20 mL) in a 50 mL
round-bottom flask, with constant heating at 90°C and stirring. A separate solution of magnesium
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oxide (MgO – 0.336 g, 8.33 mmol) was taken up in DI H2O (~20 mL), with an addition of citric
acid (CA – 0.364 g, 2.08 mmol (0.25 eq.)), constantly stirred and heated to 90°C. The MgO/CA
solution was added to the HG2 solution – upon addition, the combined solution turned an opaque
white, and was observed as translucent white/clear after about 10 minutes and up until reaction
completion. The reaction was left to run for 1hr at 90°C. The reaction was cooled to room
temperature, centrifuged to pellet any remaining solid, and the supernatant filtered through a 40μm
filter. The pH of the solution was noted as 10.2. The solution was concentrated in vacuo to
approximately 3 mL and the solid precipitated with anhydrous ethanol. Centrifugation was
employed to pellet the solid, and the ethanol was decanted off. The solid was triturated with diethyl
ether ad libitum and then recentrifuged. The ether was decanted off. To ensure no trace solvent,
the solid was reconstituted in DI H2O (~50 mL), flash frozen, and dried in vacuo on a lyophilizer.
The dried material was collected and massed to 1.28 g. Yield was found to be 72%, relative to
magnesium, and 82.6% pure with a 17.3% impurity attributed to magnesium citrate. The solubility
of 3 was determined to be 39.40 ± 2.84 g/100 mL. 3: 1H NMR (D2O, 400MHz): δ 3.76 (s, 2H, H2),
3.38 (s, 2H, H1). ESMS m/z: [Mg(G2) + H+]+ calcd for Mg(C4H7N2O3) 155.4; found 155, [3 + H+]1+
calcd for [MgC4H12N2O6 +H+]1+ 209.5; found 210. By ICP (Mg(C4H7N2O3)(H2O)(OH) • 5H2O ):
Mg = 8.78% and N = 9.89%. These values are consistent with a species of composition
Mg(G2)(H2O)(OH) × 5 H2O, with theoretical nitrogen and magnesium values for this species are
Mg = 8.66% and N = 9.99%. Utilizing the Mg:N ratio, the experimental ratio of M:N = 0.89 and
is consistent with the theoretical value of Mg:N = 0.87.
5.2.4. Synthesis of Magnesium Glycylglycylglycine (Mg(C6H10N3O4)(H2O)2(OH)) (4)
A 1.0025g sample of triglycine (HG3 – 5.29 mmol; 1 eq.) was dissolved in 10mLs of 18
MΩ H2O in a 50mL round-bottom flask, with constant stirring at 90°C. A separate solution of
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215.5 mgs magnesium oxide (MgO – 5.29 mmol; 1eq.) was taken up in 10mLs of 18MΩ H2O,
with an addition of 253.6 mgs of citric acid (CA - 0.25 eq), constantly stirred and heated to 90°C.
The MgO/CA solution was subsequently added to the triglycine solution. Immediately upon
addition, the combined solution turned a milky white color, whereupon this became a clear solution
after ~ 20min with stirring at 90°C. The reaction was run for 2 hr, and then cooled to room
temperature. The pH of the solution was noted as 10.2. The solution was concentrated to
approximately 3 mL via rotary evaporation, and a white solid was precipitated with anhydrous
ethanol. The solid was isolated by centrifugation at 4000rpm at room temperature for 10min, and
the ethanol decanted off. The solid was triturated with diethyl ether, recentrifuged as before, the
ether decanted off, and the solid dried in vacuo overnight. The dried white material was collected,
and the yield obtained. The solubility of 4 was determined to be 169 ± 12.5 g/100 mL H2O and the
purity was found to be 90+% via 1H NMR integration.
5.3. Crystal Structure Determination of 5 and 6 (see thumb drive for CIF files)
All work in this chapter was completed by the author unless otherwise stated. Crystal
structure data collection and refinement was completed by Dr. William W. Brennessel at the
University of Rochester, Rochester, New York, United States.
5.3.1. Data Collection and Refinement of 5
5.3.1.1. Data Collection of 5
A crystal (0.201 x 0.046 x 0.026 mm) of 5 was placed onto a thin glass optical fiber or a
nylon loop and mounted on a Rigaku XtaLAB Synergy-S Dualflex diffractometer equipped with
a HyPix-6000HE HPC area detector for data collection at 100.0(1) K. A preliminary set of cell
constants and an orientation matrix were calculated from a small sampling of reflections.1 A short
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pre-experiment was run, from which an optimal data collection strategy was determined. The full
data collection was carried out using a PhotonJet (Cu) X-ray source with frame times of 0.24 and
0.96 seconds and a detector distance of 31.2 mm. Series of frames were collected in 0.50º steps in
w at different 2q, k, and f settings. After the intensity data were corrected for absorption, the final
cell constants were calculated from the xyz centroids of 11301 strong reflections from the actual
data collection after integration.
5.3.1.2. Structural Refinement of 5
The structure was solved using SHELXT and refined using SHELXL.2,3 The space group
P-1 was determined based on intensity statistics. Most or all non-hydrogen atoms were assigned
from the solution. Full-matrix least squares/difference Fourier cycles were performed which
located any remaining non-hydrogen atoms. All non-hydrogen atoms were refined with anisotropic
displacement parameters. N-H and O-H hydrogen atoms on ligands that are involved in hydrogen
bonding were found from the difference Fourier map and refined freely. Due to the disorder of
the solvate water molecules over general and special positions, hydrogen atoms were placed in
positions reasonable for hydrogen bonding and given rigid riding models; it should be noted that
there may be other hydrogen bonding scenarios in addition to the one applied. All C-H hydrogen
atoms were placed in ideal positions and refined as riding atoms with relative isotropic
displacement parameters. The final full matrix least squares refinement converged to R1 = 0.0443
(F2, I > 2s(I)) and wR2 = 0.1222 (F2, all data).
Structure manipulation and figure generation were performed using Olex2.4 Unless noted
otherwise all structural diagrams containing anisotropic displacement ellipsoids are drawn at the
50 % probability level. Images of the crystal packing were generated using CrystalMaker®.5 Table
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1 provides a summary of the crystal data and structure refinement for the structural studies of
compound 1. CCDC 2101440 contains the supplementary crystallographic data for 5.

5.3.2. Data Collection and Refinement of 6
5.3.2.1. Data Collection of 6
A crystal (0.347 x 0.073 x 0.035 mm3) was placed onto a thin glass optical fiber or a nylon loop
and mounted on a Rigaku XtaLAB Synergy-S Dualflex diffractometer equipped with a HyPix6000HE HPC area detector for data collection at 100.00(10) K. A preliminary set of cell constants
and an orientation matrix were calculated from a small sampling of reflections. A short preexperiment was run, from which an optimal data collection strategy was determined. The full data
collection was carried out using a PhotonJet (Cu) X-ray source with frame times of 0.31 and 1.24
seconds and a detector distance of 34.0 mm. Series of frames were collected in 0.50º steps in w at
different 2q, k, and f settings. After the intensity data were corrected for absorption, the final cell
constants were calculated from the xyz centroids of 12348 strong reflections from the actual data
collection after integration.1 See flash drive for additional crystal and refinement information.
5.3.2.2. Structural Refinement of 6
The structure was solved using SHELXT3 and refined using SHELXL.2 The space group P21/n
was determined based on systematic absences. Most or all non-hydrogen atoms were assigned
from the solution. Full-matrix least squares / difference Fourier cycles were performed which
located any remaining non-hydrogen atoms. All non-hydrogen atoms were refined with anisotropic
displacement parameters. The O-H hydrogen atoms were found from the difference Fourier map
and refined freely. All other hydrogen atoms were placed in ideal positions and refined as riding
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atoms with relative isotropic displacement parameters.

The final full matrix least squares

refinement converged to R1 = 0.0387 (F2, I > 2s(I)) and wR2 = 0.1116 (F2, all data). Structure
manipulation and figure generation were performed using Olex2.4 Unless noted otherwise all
structural diagrams containing anisotropic displacement ellipsoids are drawn at the 50 %
probability level. Images of the crystal packing were generated using CrystalMaker®. Table 1
provides a summary of the crystal data and structure refinement for the structural studies of
compound 1.
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Chapter 6. Current and Future Work with Other Biorelevant Divalent Metals (Zn2+)
All work in this chapter was completed by the author unless otherwise indicated. Work in
this chapter resulted in the paper
•

Case, D. R., Brennessel, W. W., Zubieta, J., Doyle, R. P. Synthesis,
Characterization and Crystal Structure of a Glycylglycinate Chelate of Zinc(II).
Results in Chem. Accepted.

And a novel crystal structure deposited to the CCDC:
CCDC 2101440; [Zn2(HG21-)4(H2O)2]·5.32H2O
A paper pursuant to the latter structure, with chemical formula Zn(C 6H6O3)2Cl2, is
currently being drafted.
6.1. Introduction
While the extent of this thesis explores the complexes produced between Mg2+ and pyrones
as well as short-chain (di- and tri-) peptides, there is still a plethora of work to be done. Analysis
of scientific literature reveals that only a handful of characterized Mg2+ complexes have been
produced, and strikingly, most of these complexes forgo the most fundamental biorelevant ligands
that may be utilized to produce viable Mg2+ supplements: monomeric amino acids. To this end,
the synthesis and characterization of a library of compounds of this type should be fervently
evaluated.
Additionally, while the implications of Mg2+ deficiency were discussed at length, this does
not mean that the negative impacts of Mg2+ on optimum biological function are singular or
mutually exclusive. Much like Mg2+, other divalent metals such as zinc (Zn2+) have far-reaching
implications in biology.
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One of the most abundant trace elements, second only to iron (Fe2+/3+), Zn2+ is found
ubiquitously in biology and plays a critical role in many biological processes.1 Zn2+ deficiency
impacts cognitive function.2 More specifically, high concentrations of Zn2+ in “zinc containing”
neurons in the forebrain2 and implications in the release of neurotransmitters (e.g. GABA, etc.)2,3
suggest a substantial role in neuronal excitation. Furthermore, Zn2+ has been shown to impact the
development of children,4,5 as well as immune system function.6
The use of Zn2+ supplements has been shown to effectively assuage the negative impacts
of Zn2+ deficiency.7 As such, having observed the promise of the synthesized Mg2+ complexes,
the synthesis of Zn2+ analogues was probed with the aim of full solution- and solid-state
characterization, which provides imperative insight for proper dosing as well as possible modes of
action. Preliminary data for the syntheses of these compounds is provided and a means of
determining cellular uptake in future studies is discussed.

6.2. Current Work
6.2.1. Solid- and Solution-State Characterization of Zinc Complexes
6.2.1.1. Zinc Diglycine (5) Preliminary Data
6.2.1.1.1. Synthesis of 5
A 1.0 g sample of HG2 (7.57 mmol, 2eq.) was suspended in ca. 10 mL of DI H2O in a
round-bottom flask and heated with constant stirring to 90°C. In a separate vessel, a 0.308 g sample
of zinc oxide (3.78 mmol, 1eq.) was suspended in 10 mL of DI H2O and heated with constant
stirring to 90°C. The solutions were combined via slow addition over 10 min until the zinc oxide
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was no longer wholly soluble, and a white, semi-translucent solution remained. The solution was
reacted for up to 1hr at 90°C. The solution was cooled to room temp. After cooling, the mixture
was centrifuged to pellet the solid at 2000 rpm for 5 min, and the remaining supernatant was
decanted and filtered through a 45 μm filter. The now clear and colorless solution was flash frozen
in liquid nitrogen and dried in vacuo on a lyophilizer. The isolated product was massed to 1.03 g
resulting in a yield of 79% based on zinc. Elemental Analysis Calcd. for Zn2C16H32N8O14,
[Zn(HG21-)4(H2O)2]: C, 27.8; H, 4.67; N, 16.2. Found: C, 27.0; H, 4.95, N, 15.7. IR: 3264 cm-1,
3090 cm-1.
6.2.1.1.2. Compositional Determination of 5 Via Thermal and Elemental
Analyses
Thermogravimetric analysis (TGA) of HG2 exhibited a single, gradual percent weight
decrease onset at 220°C (inflection point observed at 270°C), which is consistent with the melting
point of HG2 at 220°C. TGA analysis of 5 exhibited three observable percent weight changes that
corresponded to three distinct endothermic events on the differential scanning calorimetry (DSC)
spectrum at 140°C, 220°C, and 280°C, respectively (Figure 1).
The endotherm observed at 140°C coincides with a 5.5% weight decrease and is attributed
to loss of coordinated water (5.21% calculated). The secondary endotherms at 220°C and 280°C
are attributed to HG21- decomposition and exhibit a gradual weight loss of nearly 80.0%, which is
consistent with the projected weight loss calculated for the loss of four HG21- ligands (76%)
Additionally, given the equivalent intensity of the endotherms at 220°C and 280°C it is believed
these are attributed to the different coordination modes of the HG21- ligand, thus resulting in
different decomposition temperatures. It is most likely the case that the endotherm at 220°C is

110

attributed to the HG21- ligand forming a five-member ring and the endotherm at 280°C is the more
thermodynamically stable bridging HG21- ligand.

Figure 22. Thermal analyses spectra of 5 including the TGA of HG2 (green),
TGA of 5 (red) and the DSC of 5.

Elemental analysis values are consistent with thermal analyses observations and provide
experimental values of C = 27.0, H = 4.95, and N = 15.7. These values were consistent with the
elemental values predicted for a complex composition of Zn2C16H32N8O14, [Zn(HG21-)4(H2O)2]: C
= 27.8, H = 4.67, and N = 16.2.

111

6.2.1.1.3. Structural Determination of 5 Via Fourier Transform Infrared (FTIR)
Infrared analysis indicated a substantial shift to lower frequency of the band attributed to
the carboxylic acid of HG2 (~26 cm-1) (Figure 2). This shift to lower frequency is assigned to zinc
coordination, at the carboxylic acid, consistent with prior literature.8

Figure 23. FT-IR spectra of HG2 and 5.
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6.2.1.1.4. Determining the Coordination Mode of HG2 Via 1H and 13C NMR
The 1H NMR spectrum of 5 exhibited an upfield shift of the signal attributed to the proton
of the carbon adjacent to the amine group in comparison to that of HG2, indicative of coordination
to the amine nitrogen (Figure 3). The shift was substantial in nature having shifted from 3.84 ppm
to 3.69 ppm (Δ = 0.15 ppm). While the observed shift is not as large in magnitude as the shift
observed upon coordination to Mg2+ (see Chapter 2), this is readily attributed to differences in
electropositivity.

Figure 24. 1H NMR overlay of HG2 (top) and 5 (bottom). NMR conducted in
D2O.
There was no observed change to the integration of the peaks attributed to HG2. Additionally, there
were no additional peaks observed after the reaction of HG2 and zinc, suggesting no production of
products secondary to the observed 5.
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Comparison of the 13C NMR spectra of 5 and HG2 showed only a substantial downfield
shift of the signal attributed to the carbonyl group of the peptide linkage (Figure 4). Furthermore,
there is a substantial decrease in the signal intensity of this peak relative to that observed for HG2
(Figure 4). These observations are consistent with those made for magnesium maltol (see Chapter
2).

5

Figure 25. 13C NMR overlay of HG2 and 5. NMR conducted in D2O.

The shift and decrease in intensity of the signal suggest zinc coordination to the oxygen of
this carbonyl group. Similar observations have been made for the coordination of other divalent
cations (e.g., Mg2+) coordinating to carbonyls.9,10 As was the case with 3, 2D NMR confirmed the
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assignments of all carbon and proton signals (see carbon and proton assignments for HG2 in
Chapter 2).
6.2.1.1.5. Isolation of X-ray Quality Crystals of 5
In a 15mL falcon tube, 1 was added to 10 mL H2O unto saturation (determined by residual
solid remaining at the bottom of the tube). The solution was centrifuged at 4000 rpm for 5 min,
when the remaining solid was sufficiently pelleted. After centrifugation, the saturated supernatant
was pipetted and transferred to a clean 20 mL glass vial, and two or three drops of water were
added. The vial was sealed with parafilm, which was pierced with several small holes to allow for
evaporation. After 7 to 8 days, small, needle-like crystals formed, which were collected for SCXRD analysis.
6.2.1.1.6. Determining the Crystal Structure of 5 Via Single Crystal Analysis
The solid-state chemistry of metal-HG2 complexes exhibits considerable versatility, as
expected from the presence of four potential binding sites on the ligand: the amine nitrogen, the
carbonyl oxygen of the amide linkage, the amide nitrogen, and the carboxylate oxygen. A number
of metal-HG2 complexes have been reported across the literature. As shown in Figure 5, the most
common coordination mode is Type I, tridentate coordination through the amine nitrogen, the
peptide nitrogen, and the carboxylate oxygen with the ligand in the deprotonated G22- form.11–14
Protonated and bridging variants of this coordination mode have also been described, Types II and
IIa.15,16 Bidentate coordination through the amine nitrogen and the peptide carbonyl group has also
been observed as in Type III17–19 and the bridging variants Types IIIa and IIIb.20,21 Monodentate
zwitterionic coordination through the peptide carbonyl group or through a carboxylate oxygen are
also known, Types IV and Iva.22,23 Bridging through the carboxylate oxygen atoms as in the copper
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acetate prototype with the ligand in the zwitterionic state has been reported in several instances,
Type V.24,25

Figure 26. Reported coordination modes of metal-HG2 complexes.
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Figure 27. A view of the binuclear structure of 5, showing the atomlabelling scheme and 50% thermal ellipsoids. Waters of crystallization are
omitted for clarity.

As shown in Figure 6, the structure of [Zn2(HG21-)4(H2O)2] consists of a centrosymmetric
binuclear complex with the zinc(II) sites exhibiting {N2O4} six coordination through bonding to
the amine termini and peptide carbonyl oxygen donors of two HG21- ligands, the carboxylate
oxygen of one of the HG21- ligands on the adjacent zinc site, and the oxygen of an aqua ligand.
The nitrogen donors adopt a trans orientation, while the aqua ligand is trans to one amide carbonyl
oxygen and carboxylate oxygen is trans to the second amide carbonyl oxygen donor.
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Two different binding modes are adopted by the HG21- ligands. More specifically, Type III
(Figure 5), with the terminal amine and the amide carbonyl oxygen of one ligand at each zinc site
binding in a bidentate fashion, and Type IIIa (Figure 5), again with the amine nitrogen and the
peptide carbonyl oxygen binding in the same way but with the terminal carboxylate oxygen
bridging to the adjacent zinc center of the binuclear unit. Thus, each zinc site binds exclusively to
one bidentate HG21- ligand, while coordinating in a bidentate fashion to a second HG21- ligand that
additionally bridges through the carboxylate oxygen to the second zinc site. The coordination
sphere at the zinc sites is completed by aqua ligation, resulting in six-coordinate geometry. The
coordination modes produce two five-membered chelate rings at each zinc site {ZnNCCO}, as
well as an unusual cyclic fourteen-membered bridging unit {ZnOCNCCO}2.

Figure 28. A view of the crystal packing of 5, showing the hydrogen bonding scheme.
Color code: Zn, large gray spheres; oxygen, red spheres; nitrogen, blue spheres; carbon,
black spheres; hydrogen, small gray spheres. Hydrogen bonds are shown as dotted lines.
Lesser contributing disordered atoms have been omitted for clarity.
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While there is some disorder of the water molecules of crystallization, these reside in the
regions between stacked [Zn2(HG21-)4(H2O)2] molecules, as observed viewing normal to the bc
crystallographic axes in Figure 7. Extensive hydrogen bonding is present between the
crystallization water molecules and the amine nitrogen atoms, as well as between the aqua ligands
and the carboxylate oxygen atoms of neighboring binuclear units and between the waters of
crystallization. Crystal data was collected and refined by Dr. William W. Brennessel at the
University of Rochester in Rochester, New York, United States.
6.2.1.2. Zinc Maltol (6) Preliminary Data
6.2.1.2.1. Isolation of X-ray Quality Crystals of 6
In a 15mL falcon tube, 6 was added to 10 mL H2O unto saturation (determined by residual
solid remaining at the bottom of the tube). The solution was centrifuged at 4000 rpm for 5 min,
when the remaining solid was sufficiently pelleted. After centrifugation, the saturated supernatant
was pipetted and transferred to a clean 20 mL glass vial, and two or three drops of water were
added. The vial was sealed with parafilm, which was pierced with several holes to allow for
evaporation. After allowing slow evaporation for 7 to 8 days, small, yellow, needle-like crystals
formed, which were collected for SC-XRD analysis.
6.2.1.2.2. Single Crystal X-ray Structure of 6
As shown in Figure 8, the structure of Zn(Malt)2Cl2 exhibits one zinc metal center
assuming a four-coordinate, tetrahedral geometry with two coordinated, neutral maltol ligands and
charge balance achieved via two chloride anions; the maltol ligands are coordinated through the
keto oxygen, and act as a monodentate ligand.
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Figure 29. A view of the tetrahedral structure of 6, showing the atom-labeling
scheme and 50% thermal ellipsoids.

Coordination in this fashion is peculiar given a well-outlined bidentate coordination of
maltol to metals of this type through the deprotonated terminal alcohol and the ketone (Figure
9).26–28

Figure 30. Supported coordination mode of maltol to biorelevant metals.

Reported crystal data provided to the CCDC indicates approximately 70 crystal structures
of metal-maltol complexes, and a smaller subset comprised of biorelevant metals such as zinc,
copper, iron, nickel, and cobalt.29 Of these complexes, there are only three reported structures
utilizing zinc, and all reported structures exhibited a bidentate coordination mode as shown in
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Figure 3. Making 6 the first reported structure of this type.
Although coordination through the terminal alcohol and the ketone is more likely given the
increased stability upon the formation of a bidentate chelate, it is likely coordination occurs in the
described fashion given a lack of deprotonation of the terminal alcohol (pKa = 8.68)30 resulting
from reaction pH at 3.1, which provides no charge balance from the ligand itself, requiring charge
balance be provided by the presence of chloride anion.

Figure 31. A view of the crystal packing in 6, showing the hydrogen bonding scheme.
Color code: Zn, large gray spheres; oxygen, red spheres; nitrogen, blue spheres; carbon,
brown spheres; hydrogen, small gray spheres. Hydrogen bonds are shown as dotted lines.

The crystal packing for 6, shown in Figure 10, exhibits no presence of extensive hydrogen
bonding or interstitial waters. Furthermore, there is little observed disorder. Additionally, the unit
cell exhibits 6 packing in a stacked fashion as sheets.
6.3. Future Work
6.3.1. Synthesis and Characterization of a Library of Mg2+- Amino Acid (MgAA) Complexes
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Provided the success of the Mg2+ complexes reported in this thesis and considering only a
pittance of fully characterized Mg2+ complexes throughout the literature31–33 there is a need to
develop and characterize a library of complexes comprised of MgAA compounds given that amino
acids are the most fundamental biorelevant ligands feasible.
In lieu of magnesium oxide (MgO) as a starting material, magnesium carbonate (MgCO3)
will be utilized given a substantial increase in water solubility relative to MgO as a means of
forgoing the presence of magnesium citrate as observed from the synthesis of the Mg2+-complexes
reported within.
The synthesized MgAA complexes will be characterized in a similar fashion to the
previously reported Mg2+-complexes with both 1D and 2D 1H/13C NMR as the primary means of
determining preliminary ligand coordination to Mg2+ and solid-state analyses utilized to confirm
complex composition. It is hypothesized that most amino acids will exhibit Mg2+ coordination
predominantly to the deprotonated carboxylic acid in favor of the hard-hard acid-base chemistry
of Mg2+, however, where possible, ligand coordination may occur in favor of entropically favored
ring structures (e.g. aspartic acid, glutamic acid, phenylalanine, etc.), or in higher order (tri- and
tetradentate) thus providing stability through increased entropy as well (e.g. arginine, threonine,
etc.). Furthermore, the varying chemical characteristics of these ligands (acidic/basic,
polar/nonpolar, aliphatic/aromatic, etc.) provide integral insight into what truly impacts observed
Mg2+ uptake.

6.3.2. Completing Mg2+-Complex Uptake In Vitro and In Vivo
Successful screening of the previously discussed Mg2+ complexes suggest the provided
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Mg2+ uptake assay protocol as a viable means of determining Mg2+ uptake in vitro. As such, all
complexes produced in the future will be screened for in vitro uptake in the same fashion. Having
screened all Mg2+ complexes in vitro, the most promising compounds will be screened in vivo in
rats.
6.3.3. Assaying Cellular Uptake of Zn2+- Complexes in CaCo-2 Cells
6.3.3.1. Assaying the In Vitro Uptake of Zn2+ from 5 and 6
As was the case concerning the in vitro evaluation of the uptake of Mg2+ from the Mg2+complexes, the cellular uptake of Zn2+ from the Zn2+-complexes may be evaluated in the same
fashion. Provided the crystal structures of 5 and 6, determining dosing is much more simplified.
Zn2+ uptake may be evaluated utilizing a colorimetric assay again provided by BioVision
(Milpitas, CA, USA). CaCo-2 Cells will be treated in with the zinc complexes relative to zinc
chloride (ZnCl2) for a period of 1-2 hrs, cells will be lysed, and intracellular contents replated and
developed to confirm presence of Zn2+.
6.3.4 Crystallization of Synthesized Mg2+ and Zn2+Complexes
While the combination of both solution- and solid-state analyses has proved advantageous
in determining complex composition and ligand coordination mode, attaining crystal structures of
the produced compounds is ideal. Crystallization attempts in the form of slow evaporation, vaporliquid diffusion, liquid-liquid diffusion, and sol-gel will be utilized. Additionally, different solvent
systems will be employed to take advantage of differences in compound solubility.
While Mg2+-complex crystallization is complicated by the substantial amount of disorder
afforded to said complexes attributed to rapid hydration, the successful crystallization of Zn2+
complexes should be much more fruitful given promising results for Zn2+-complex crystallization
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presented previously in this chapter and a decrease in overall disorder imparted by water.
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Appendix B: Crystallographic Information Files (USB)
1. [Zn2(HGG1-)4(H2O)2]·5.32H2O, 5
2. Zn(C6H6O3)2Cl2, 6
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